NZ270235A - Substituted sulphonyloxy benzophenone hydrazone derivatives; pesticides - Google Patents
Substituted sulphonyloxy benzophenone hydrazone derivatives; pesticidesInfo
- Publication number
- NZ270235A NZ270235A NZ270235A NZ27023594A NZ270235A NZ 270235 A NZ270235 A NZ 270235A NZ 270235 A NZ270235 A NZ 270235A NZ 27023594 A NZ27023594 A NZ 27023594A NZ 270235 A NZ270235 A NZ 270235A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- halo
- compound
- spp
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/76—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
- A01N41/04—Sulfonic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/24—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing the groups, or; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
- A01N47/34—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/56—Amides of thiocarboxylic acids having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
- C07C329/12—Dithiocarbonic acids; Derivatives thereof
- C07C329/14—Esters of dithiocarbonic acids
- C07C329/16—Esters of dithiocarbonic acids having sulfur atoms of dithiocarbonic groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/14—Dithiocarbamic acids; Derivatives thereof
- C07C333/18—Esters of dithiocarbamic acids
- C07C333/20—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/14—Dithiocarbamic acids; Derivatives thereof
- C07C333/18—Esters of dithiocarbamic acids
- C07C333/28—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C337/02—Compounds containing any of the groups, e.g. thiocarbazates
- C07C337/04—Compounds containing any of the groups, e.g. thiocarbazates the other nitrogen atom being further doubly-bound to a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C337/06—Compounds containing any of the groups, e.g. thiosemicarbazides
- C07C337/08—Compounds containing any of the groups, e.g. thiosemicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. thiosemicarbazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/21—Radicals derived from sulfur analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pretreatment Of Seeds And Plants (AREA)
Abstract
Sulphonyloxy-substd. benzophenone hydrazone derivs. of formula (I) and their salts are new: R1, R17 = halo; 1-8C alkyl or alkylthio opt. substd. by halo; Ph; OPh; SPh; 1-8C alkylcarbonyl;etc.; m = 0-4; n - 0-5; X = S, R2 = R21 or H and R3 = R31, -NR5R6 or -OR2; or X = O, R2 - R21 and R3 = R31; or X = O, R2 = H and R3 = R8OR9, -R8OCOR9, -R8NR10R11 or =R8R12; or X and R3 together form R18; Y = O or S; R4 = 1-8C alkyl opt. substd. by halo; or halo- 1-8C alkoxy; R21 = 1-8C alkyl opt. substd. by halo; 1-4C alkyl substd. by 1-4C alkoxy,etc.;R31 = H; 1-8C alkyl opt. substd. by halo;etc.;R5, R6 = H; 1-8C alkyl opt. substd. by halo;etc.;R7 = H; 1-8C alkyl opt. substd. by halo; or 2-8C alkenyl; R8 = C(R15R16)p; p = 1-4; R9 = 1-8C alkyl; halo-substd. alkyl or alkenyl with up to 11C;etc.;R11 = 1-8C alkyl,etc.;R12 = satd. or unsatd 5- or 6 membered heterocyclic or heterobicyclic ring contg. 1-3 O, N and/or S atoms,etc.;R13, R14 = H or 1-8C alkyl; R15, R16 = H, 1-8C alkyl;etc.;R18 = NC(R19)=C(R19)Y;etc.;R19 = H; halo; or 1-4C alkyl opt. substd. by halo;cpds. (I) are excluded when R2 = H and (a) m = 0, n = 1, R1 = 4-Cl, R3 = -N(OMe)Me or -NHNH2, R4 = CF3 and X = O; or (b) m = 0, n = 2, R1 = 3,4-diCl, R3 = -N(OMe)Me, R4 = CF3 and X = O.
Description
<div class="application article clearfix" id="description">
<p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number £70235 <br><br>
270? ^^ <br><br>
w L, uj <br><br>
Priority Date(s): <br><br>
Complete Specification Fifed: <br><br>
Class: (6) Co^.^^l«S'.<3l3?3?0^3W:^a <br><br>
8Qir&§i!P/..te>.t^ <br><br>
Publication Date: .?..!? <br><br>
P.O. Journal No: I.Wr.lf?. <br><br>
NO DRAWINGS <br><br>
Class Cont: <br><br>
Aoinii+3] co. la.tfo/sc^sa, ioH-1 su-. <br><br>
Patents Form No. 5 <br><br>
Our Ref: JB204179 <br><br>
NEW ZEALAND PATENTS ACT 1953 COMPLETE SPECIFICATION <br><br>
HYDRAZONE DERIVATIVES <br><br>
tiJSL PATGNT OFFICE <br><br>
21 DEC 1994 <br><br>
We, CIBA-GEIGY AG, a Swiss Corporation, of Klybeckstrasse 141, 4002 Basle, Switzerland hereby declare the invention, for which We pray that a patent may be granted to us and the method by which it is to be performed, to be pcirticularly described in and by the following statements <br><br>
PT0597907 <br><br>
(followed by page la) <br><br>
- 1 - <br><br>
PI/5-19820/A <br><br>
- la- <br><br>
270235 <br><br>
Hvdrazone derivatives <br><br>
The invention relates to compounds of formula <br><br>
(Ri) <br><br>
(D, <br><br>
wherein m is 0,1,2,3 or 4, and, when m is greater than 1, the radicals R17 are identical or different; <br><br>
n is 0,1,2,3,4 or 5, and, when n is greater than 1, the radicals are identical or different; <br><br>
Rj and R17 are each independently of the other, halogen, C-j-Cgalkyl, halo^C-j-Cgalkyl, phenoxy, phenylthio, halo-Cj-Cgalkylthio, phenyl, CrCgalkylthio, Cj-Cgalkyl-carbonyl, 0S02R4, S02NR13R14 or P(=Y)R22R23; <br><br>
either X is S, R2 is R21 or H and R3 is R31, -NRgRg or -OR2, <br><br>
or X is O, R2 is R21 and R3 is R31, <br><br>
or X is O, R2 is H and R3 is -RgORg, -RgOCOR^, -RjNRjqRjj or -RjRj2, <br><br>
or X and R3 together are R18; <br><br>
Y isOorS; <br><br>
R4 is CrC8alkyl, halo-CrCgalkyl or halo-CVCgalkoxy; <br><br>
R21 is CrC8alkyl, C3-C6cycloalkyl, halo-CrC8alkyl, CrC4alkoxy-C1-C4alkyl, CrC4-alkylthio-CpQalkyl, R13R14N-C1-C4alkyl, C2-C8alkenyl, C2-C8alkynyl, CrC4acyl, CH=C(CN)2, or phenyl which is unsubstituted or substituted by from one to five substituents selected from the group consisting of halogen, CrC4alkyl, C2-C5-alkenyl, halo-CrC4alkyl, Cj-Qalkoxy, S02NR13R14, halo-CrC4alkoxy, CrC4-alkylthio, C]-C4alkoxy-C1-C4alkoxy, halo-CrC4alkylthio, NR13R14, -N02 and -CN; R31 is H, CrC8alkyl, C3-C6cycloalkyl, C3-C6cycloalkyl-C1 -C3alkyl, halo-C,-C8alkyl, halo-C3-C6cycloalkyl-CrC3alkyl, C2-C8alkenyl, C2-C8alkynyl, halo-C2-C8alkenyl, -COOR7, -SR2, -R8OR9, -RjjOCORj, -RJJNRjqRJ j, -R8R]2, -RgSRy, -R8SCSRQ, <br><br>
phenyl which is unsubstituted or substituted by Irom one to live substituents selected from the group consisting of halogen, C,-C4alkyl. C2-C5alkenyl, halo-Cj-Qalkyl, halo-CpCjiilkoxy, halo-C|-Cdalkylthio, CrC,,alkoxy, -N()2 and -CN; <br><br>
270235 <br><br>
-2- <br><br>
g i an unsubstituted or substituted, saturated or unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group consisting of halogen, CrC4alkyl, halo-CrC4alkyl and CrC4alkoxy; <br><br>
R5 and R6 are each independently of the other H, Cj-Cgalkyl, halo-Cj-Cgalkyl, <br><br>
C2-Csalkenyl, C1-C4alkoxy, C2-C5alkenyloxy or R7 is H, Cj-Cgalkyl, halo-CrC8alkyl or Q-Cgalkenyl; <br><br>
Rg is (CR15R16)p, wherein p is 1,2,3 or 4; <br><br>
Rg is C1-C8alkyl, halo-C1-C11alkyl, C3-C6cycloalkyl, C2-C8alkenyl, halo-C2-Cn- <br><br>
alkenyl, C2-Cgalkynyl, NR10RU, ORjq, benzyl, or phenyl which is unsubstituted or substituted by from one to five substituents selected from the group consisting of halogen, C1-C4alkyl, C2-C5alkenyl, halo-Cj-Qalkyl, C^-Qalkoxy, -N02 and -CN; R10 and Rn are each independently of the other Cj-Cgalkyl, Gj-Cgalkenyl or C1-C8-alkoxy-CrC8alkyl; <br><br>
R12 is an unsubstituted or substituted, saturated or unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group consisting of halogen, CrC4alkyl, halo-Cj-^alkyl and CrC4alkoxy; <br><br>
R13 and R14 are each independently of the other H or C1-C8alkyl; <br><br>
R15 and R16 are each independently of the other H, Cj-Cgalkyl, or phenyl which is unsubstituted or substituted by from one to five substituents selected from the group consisting of halogen, C1-C4alkyl, C^-Csalkenyl, halo-C1-C4alkyl, C1-C4alkoxy, -N02 and -CN; <br><br>
Rig is NC(R19)=C(R19)S, NC(R19)=C(R19)0, NC(Ri9)2C(Ri9)2S, NC(Ri9)2C(R19)20, <br><br>
NC(R19)=C(R19)C(R19)=N or NC(R19)=NC(R19)=N; <br><br>
R19 is H, CrC4alkyl, halogen or halo-Cj-Qalkyl; <br><br>
R22 is Cj-C4alkyl, CrC4alkoxy or NR13R14; and R23 is CrC4alkyl, CrC4alkoxy, C3-C4alkylthio or NR13R14, <br><br>
with the proviso that, in the compounds of formula I, R2 is other than H when either m is 0, n is 1, Rj is 4-C1, R3 is -N(OCH3)CH3, R4 is CF3 and X is S, or when m is 0, n is 2, Rj is 3,4-dichloro, R3 is -N(OCH3)CH3, R4 is CF3 and X is S or when m is 0, n is 1, Rj is 4-C1, R3 is -NHNH2, R4 is CF3 and X is S, and, as the case may be, tautomers thereof, in each case in free form or in salt form; <br><br>
to a process for the preparation of and lo the use of those compounds and tautomers, to pesticidal compositions in which the active ingredient has been selected from those <br><br>
270 <br><br>
-3- <br><br>
acceptable salt, and to a process for the preparation of and to the use of those compositions. <br><br>
Certain hydrazone derivatives are proposed in the literature as insecticidally active ingredients in pesticides. The biological properties of those known compounds are not, however, entirely satisfactory in the area of pest control and, therefore, there is a need to provide further compounds having pesticidal properties, especially for the control of insects, ectoparasites and representatives of the order Acarina. This problem is solved according to the invention by the provision of the present compounds I. <br><br>
Some of the compounds I may be in the form of tautomers. If, for example, R2 is H, corresponding compounds I, that is to say those having a -N(H)-C(R3)=X partial structure, may be in equilibrium with the respective tautomers having a -N=C(R3)-XH partial structure. Accordingly, hereinafter there is to be understood by compounds I, where appropriate, also corresponding tautomers, even if the latter are not specifically mentioned in every case. <br><br>
The compounds I and, as the case may be, their tautomers may be in the form of salts. Compounds I having at least one basic centre may form, for example, acid addition salts. These are formed, for example, with strong inorganic acids, such as mineral acids, e.g. sulfuric acid, a phosphoric acid or a hydrohalic acid, with strong organic carboxylic acids, such as unsubstituted or substituted, for example halo-substituted, C1-C4alkanecarboxylic acids, e.g. acetic acid, saturated or unsaturated dicarboxylic acids, e.g. oxalic, malonic, maleic, fumaric or phthalic acid, hydroxycarboxylic acids, e.g. ascorbic, lactic, malic, tartaric or citric acid, or benzoic acid, or with organic sulfonic acids, such as unsubstituted or substituted, for example halo-substituted, C1-C4alkane- or aryl-sulfonic acids, e.g. methane- or p-toluene-sulfonic acid. Compounds I having at least one acid group may furthermore form salts with bases. Suitable salts with bases are, for example, metal salts, such as alkali metal salts and alkaline earth metal salts, e.g. sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower alkylamine, e.g. ethylamine, diethyl-amine, triethylamine or dimethylpropylamine, or a mono-, di- or tri-hydroxy-lower alkylamine, e.g. mono-, di- or tri-ethanolamine. Furthermore, corresponding internal salts may also be formed. Within the scope of the invention, agrochemically advantageous salts are preferred; also included, however, are salts that have disadvantages for agrochemical applications, for example salts that are toxic to bees and to fish, which can be used, for <br><br>
27023 <br><br>
- 4- <br><br>
example, for the isolation and purification of free compounds I or their agrochemically acceptable salts. In view of the close relationship between the compounds I in free form and in the form of their salts, hereinbefore and hereinafter any reference to the free compounds I or their salts is to be understood as including also the corresponding salts or the free compounds I, respectively, where appropriate and expedient The same applies to tautomers of compounds I and their salts. <br><br>
Unless defined otherwise, the general definitions used hereinbefore and hereinafter have the meanings given below. <br><br>
Halogen - as a group per se and as a structural unit of other groups and compounds, such as of haloalkyl, halocycloalkyl and haloalkenyl, - is fluorine, chlorine, bromine or iodine, especially fluorine, chlorine or bromine, more especially fluorine or chlorine. <br><br>
Unless defined otherwise, groups and compounds containing carbon each contain from 1 up to and including 8, preferably from 1 up to and including 4, especially 1 or 2, carbon atoms. <br><br>
C3-C6cycloaIkyl is cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. <br><br>
Alkyl - as a group per se and as a structural unit of other groups and compounds, such as of haloalkyl, alkoxy and alkylthio, - is, duly taking into account the number of carbon atoms contained in the group or compound in question, either straight-chained, i.e. methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl or octyl, or branched, e.g. isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl or isooctyl. <br><br>
Halo-substituted carbon-containing groups and compounds, such as haloalkyl, halocycloalkyl or haloalkenyl, may be partially halogenated or perhalogenated, and, in the case of multiple halogenation, the halogen substituents may be identical or different. Examples of haloalkyl - as a group per se and as a structural unit of other groups and compounds, such as of halocycloalkylalkyl and haloalkenyl, - are methyl substituted by from one to three fluorine, chlorine and/or bromine atoms, such as CHF2 or CF3; ethyl substituted by from one to five fluorine, chlorine and/or bromine atoms, such as CH2CF3, CF2CF3, CF2CC13, CF2CHC12, CF2CHF2, CF2CFCI2, CF2CHBr2, CF2CHC1F, CF2CHBrF or CC1FCHC1F; propyl or isopropyl substituted by from one to seven fluorine, chlorine and/or bromine atoms, such as CH2CHBrCH2Br, CF2CHFCF3, CH2CF2CF3 or CH(CF-,)2; and butyl or <br><br>
270235 <br><br>
one of its isomers substituted by from one to nine fluorine, chlorine and/or bromine atoms, such as CF(CF3)CHFCF3 or CH2(CF2)2CF3. <br><br>
Acyl groups may be formyl, acetyl, propionyl, butyryl or isobutyryl. <br><br>
Examples of saturated heterocyclic rings are pyrrolidinyl, piperidyl and morpholinyl, and examples of unsaturated heterocyclic and heterobicyclic rings are thienyl, pyrryl, imid-azolyl, pyrazolyl, triazolyl, thiazolyl, isothiazolyl, pyridyl, iridolyl, benzo[b]thienyl and 'oenzo[b]furyl. <br><br>
Preferred embodiments within the scope of the invention, talcing into account the proviso mentioned above, are: <br><br>
(1) A compound of formula I wherein m is 0,1 or 2, preferably 0 or 1, especially 0, and, when m is greater than 1, the radicals R17 are identical or different, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(2) A compound of formula I wherein n is 1, 2 or 3, <br><br>
preferably 1 or 2, <br><br>
especially 1, <br><br>
and, when n is greater than 1, the radicals Rj are identical or different, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(3) A compound of formula I wherein <br><br>
Rt is halogen, C1-C4alkyl or halo-Cj^alkyl, <br><br>
preferably halogen, <br><br>
especially fluorine, chlorine or bromine, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(4) A compound of formula I wherein either X is S, R2 is R2J and R3 is R31, ~NR5R6 or -OR2, <br><br>
especially X is S, R2 is R21 and R3 is R31; <br><br>
or X is O, R2 is R21 and R3 is R3i; <br><br>
or X is O, R2 is H and R3 is -R8OR9, -R8OCOR9, -RgNR^R!, or -Rg^iC' <br><br>
especially X is O, R2 is H and R-, is -R8OR9; <br><br>
(5) A compound of formula I wherein <br><br>
R2i is Cj-C4alkyl, C3-C6cycloalkyl, C2-C4alkenyl, C2-C4alkynyl, C1-C2acyl or phenyl, preferably CrC4alkyl, C3-C6cycloalkyl, CrC4acyl or phenyl, <br><br>
especially C1-C4alkyl, formyl or acetyl; <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(6) A compound of formula I wherein <br><br>
R31 is H, Ci-C6alkyl, C3-C6cycloalkyl, C3-C6cycloalkylmethyl, halo-Cj-C4alkyl, halo-C3-C6cycloalkylmethyl, C2-C4alkenyl, C2-C4alkynyl, halo-C2-C4alkenyl, -COOR7, -SR2, -RgORg, -RgOCORg, -R.gNR.joRu, "RgSR^, -RgSCSR^, phenyl or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group consisting of halogen, Ci-Qalkyl and CrC4alkoxy, <br><br>
preferably H, CrC6alkyl, C3-C6cycloalkyl, halo-C1-C3alkyl, halo-C3-C6cycloalkylmethyl, C2-C4alkenyl, halogen, -COOR7, -SR2, -RgOR^, -RgOCORg, -RgNRjgRj j, -RgRj2, phenyl or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group halogen; especially H, Cj-Qalkyl, C3-C6cycloalkyl, halo-C1-C2alkyl, halocyclopropylmethyl, C2-C4alkenyl, fluorine, chlorine, -SR2, -R8OCOR9, -RgR^ or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing N or S, the substituents being selected from the group fluorine and chlorine, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(7) A compound of formula I wherein R4 is CrC4alkyl or halo-CrC4alkyl, <br><br>
preferably halo-Q-Qalkyl, <br><br>
especially haIo-CrC2alkyl, <br><br>
most especially trifluoromethyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(8) A compound of formula 1 wherein <br><br>
R5 and Rr, are each independently of the other H, C,-C4alkyl, halo-CrC4alkyl, <br><br>
- 7- <br><br>
C2-C4alkenyl, CrC3alkoxy, C2-C3alkeneoxy or -NR13R14> <br><br>
preferably H, CrC2alkyl, halo-CrC2alkyl, C2-C3alkenyl, C1-C2alkoxy, C2-C3alkeneoxy or -NR13R14> <br><br>
especially H, C1-C2alkyl, C2-C3alkenyl, CrC2alkoxy, CVQalkeneoxy or -NR13R14, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(9) A compound of formula I wherein <br><br>
R7 is CrC4alkyl, halo-CrC4alkyl or C^-Qalkenyl, <br><br>
preferably C1-C2alkyl or halo-CrC2alkyl, <br><br>
especially methyl or ethyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(10) A compound of formula I wherein R8 is (CR15R16)p, wherein p is 1,2 or 3, <br><br>
preferably 1 or 2, <br><br>
especially 1, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(11) A compound of formula I wherein <br><br>
Rg is C1-C4alkyl, halo-Q-Cnalkyl, C3-C6cycloalkyl, C2-C4alkenyl, halo- <br><br>
C2-Cnalkenyl, C2-C4alkynyl, NR10Rn, OR10, benzyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of halogen, CrC2alkyl, halo-CrC2alkyl, C1-C3alkoxy, -N02 and -CN; <br><br>
preferably Cj-Qalkyl, halo-C8-C11alkyl, C3-C5cycloalkyl, C2-C3alkenyl, halo- <br><br>
C8-Cnalkenyl, C2-C3alkynyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of fluorine, chlorine, methyl, Cj-C2alkoxy and -N02; <br><br>
especially CrC4alkyl, halo-C8-Cnalkyl, cyclopropyl, vinyl, halo-C8-Cnalkenyl, ethynyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of chlorine, methyl, methoxy and -N02; <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(12) A compound of formula I wherein <br><br>
R10 and Rn are each independently of the other CrC4alkyl, C2-C4alkenyl or <br><br>
C! -C4alkoxy-C ^ -C4alky 1, <br><br>
preferably C,-C2alkyl, C2-C3alkenyl or CrC2alkoxy-C|-C2alkyl, <br><br>
27023 <br><br>
especially methyl, allyl or methoxyethyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(13) A compound of formula I wherein <br><br>
R12 is an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group consisting of halogen, CrC4alkyl and CrC4alkoxy; <br><br>
preferably an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, <br><br>
especially an unsubstituted, unsaturated, five-membered heterocyclic ring containing from one to three hetero atoms selected from the group N and S, <br><br>
most especially imidazolyl, pyrazolyl or triazolyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(14) A compound of formula I wherein <br><br>
R13 and R14 are each independently of the other H or Cj-C4alkyl, <br><br>
preferably H or C1-C2alkyl, <br><br>
especially H or methyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(15) A compound of formula I wherein <br><br>
R15 and R16 are each independently of the other H, C^-C^alkyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of halogen, CrC2alkyl, C2-C3alkenyl, halo-Cj-C3alkyl, CpQalkoxy, -N02 and -CN; <br><br>
preferably H, CrC2alkyl or phenyl, <br><br>
especially H, methyl or phenyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(16) A compound of formula I wherein R17 is halogen or Ci-C4alkyl, <br><br>
preferably chlorine or methyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
iJ <br><br>
-9- <br><br>
(17) A compound of formula I wherein <br><br>
Rlg is NC(R19)=C(R19)S, NC(R19)=C(R19)0, NC(R19)=C(R19)C(R19)=N or <br><br>
N(R19)=NC(R19)=N, <br><br>
preferably NC(R19)=C(R19)S, NC(R19)=C(R19)0 or NC(Ri9)=C(Ri9)C(R19)=N, <br><br>
especially NC(R19)=C(R19)S or NC(R19)=C(R19)0, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(18) A compound of formula I wherein m is 0, <br><br>
n is 1, <br><br>
Rj is fluorine, chlorine or bromine, <br><br>
R2 is CrC4alkyl, C3-C6cycloalkyl, CrC4acyl or phenyl, <br><br>
R3 is H, CrC6alkyl, C3-C6cycloalkyl, halo-C1-C3alkyl, halo-C3-C6cycloalkylmethyl, C2-C4alkenyl, -COOR7, -SR2, -RgOR^, -RgOCORg, -RgNR10Rn, -RgRi2» phenyl or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group halogen, R4 is CrC4alkyl or halo-Cj-Qalkyl, <br><br>
R7 is CrC2alkyl or halo-Cj-C^alkyl, <br><br>
Rg is CRj5R16, <br><br>
Rg is CrC4alkyl, halo-Cg-Cnalkyl, C3-C5cycloalkyl, C2-C3alkenyl, <br><br>
halo-Cg-Cj jiiikenyl, C2-C3alkynyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of fluorine, chlorine, methyl, CrC2alkoxy and -N02; <br><br>
R10 and Ru are each independently of the other methyl, allyl or methoxyethyl, <br><br>
R12 is an unsubstituted, unsaturated, five-membered heterocyclic ring containing from one to three hetero atoms selected from the group N and S, and R15 and R16 are each independently of the other H, methyl or phenyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(19) A compound of formula I wherein m is 0, <br><br>
n is 1, <br><br>
Rj is fluorine, chlorine or bromine, <br><br>
R2 is C,-C4alkyl, i'ormyl or acctyl, <br><br>
R3 is H, C|-Cfialkyl, C3-C6cycloalkyl, halo-Ci-C3alkyl, halo-C3-C6cycloalkylmelhyl, <br><br>
- 10- <br><br>
270 <br><br>
C2-C4alkenyl, -COOR7, -SR2, -RgORp, -R8OCOR9, -R8NR10Rn, -R8R12, phenyl or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group halogen, R4 is halo-CrC2alkyl, <br><br>
R7 is methyl or ethyl, <br><br>
Rg is CR^Rjg, <br><br>
Rg is CrC4alkyl, halo-C8-Cnalkyl, cyclopropyl, vinyl, halo-C8-Cj jalkenyl, ethynyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of chlorine, methyl, methoxy and -N02; <br><br>
R10 and Rj x are each independently of the other methyl, allyl or methoxyethyl, <br><br>
R12 is an unsubstituted, unsaturated, five-membered heterocyclic ring containing from one to three hetero atoms selected from the group N and S, and R15 and R16 are each independently of the other H, methyl or phenyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
(20) A compound of formula I wherein m is 0, <br><br>
n is 1, <br><br>
Rt is fluorine, chlorine or bromine, <br><br>
R2 is Cj-C^alkyl, formyl or acetyl, <br><br>
R3 is H, CrC4alkyl, C3-C6cycloalkyl, haIo-CrC2alkyl, halocyclopropylmethyl, C2-C4alkenyl, -COOR7, -SR2, -R8-OCORg, -R8-Ri2 or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing N or S, the substituents being selected from the group fluorine and chlorine; <br><br>
R4 is trifluoromethyl, <br><br>
R7 is methyl or ethyl, <br><br>
Rg isCR15R16, <br><br>
Rg is CrC4aIkyl, halo-C8-Cnalkyl, cyclopropyl, vinyl, halo-C8-CHalkenyl, ethynyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of chlorine, methyl, methoxy and -N02; <br><br>
R12 is an unsubstituted, unsaturated, five-membered heterocyclic ring containing from one to three hetero atoms selected from the group N and S, and R15 and RK) are each independently of the other H, methyl or phenyl, <br><br>
or, as the case may be, a tautomer thereof; <br><br>
-11 - <br><br>
(21) A compound of formula I wherein m is 0, <br><br>
n is 1, <br><br>
Rj is fluorine, chlorine or bromine, <br><br>
R2 is CrC4alkyl, formyl or acetyl, <br><br>
R3 is H, CrC4alkyl, C3-C6cycloalkyl, halo-C1-C2alkyl, halocyclopropylmethyl, C2-C4alkenyl, -COOR7, -SR2, -R3-OCOR9, -R8-R12 or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing N or S, the substituents being selected from the group fluorine and chlorine; <br><br>
R4 is trixluoromethyl, <br><br>
R7 is methyl or ethyl, <br><br>
Rg is CH2, C(methyl)2 or CH(phenyl), <br><br>
R9 is Cj-Qalkyl, halo-Cg-C^aHcyl, cyclopropyl, vinyl, halo-C8-Cj2alkenyl, ethynyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of chlorine, methyl, methoxy and -N02; and R12 is an unsubstituted, unsaturated, five-membered heterocyclic ring containing from one to three hetero atoms selected from the group N and S, <br><br>
or, as the case may be, a tautomer thereof. <br><br>
Especially preferred within the scope of the invention are the compounds of formula I listed in Table 1 and, as the case may be, the tautomers thereof, and, most especially, the compounds of formula I mentioned in Examples P2, P3, P5 to P13, P15, P16 and P18 and, as the case may be, the tautomers thereof. <br><br>
Specifically preferred within the scope of the invention is 4-chloro-4'-trifluoromethane-sulfonyloxybenzophenone-N-formyl-N-methylhydrazone (compound 1 in Table 1). <br><br>
The invention further relates to a process for the preparation of the compounds of formula I and, as the case may be, their tautomers, taking into account the proviso mentioned above, in each case in free form or in salt form, in which process, for example, <br><br>
a) a compound of formula <br><br>
270 <br><br>
- 12- <br><br>
(Ri) <br><br>
(Ri7)m <br><br>
(H), <br><br>
N <br><br>
"NH <br><br>
which is known or can be prepared analogously to corresponding known compounds and wherein m, n, Rj, R2, R4 and R17 are as defined for formula I, or, as the case may be, a tautomer thereof, in free form or in salt form, is reacted with phosgene or thiophosgene, preferably in the presence of a base, and the intermediate, which is optionally isolated, is reacted, if desired in the presence of a base, with a compound of formula YjH, wherein Yj is -NR5R6, -OR2 or -SR2 and R2, R5 and R6 are as defined for formula I, or with a salt thereof, or b) for the preparation of a compound of formula I wherein X is O, a compound of formula II is reacted, if desired in the presence of a base, with a compound of formula R3COY2, wherein R3 is as defined for formula I with the exception of the meanings -OR2 and -SR2, and Y2 is a leaving group, or c) for the preparation of a compound of formula I wherein X is S, a compound of formula II is reacted with a compound of formula Y3-N=C=S, wherein Y3 is H, CrC8alkyl, halo-CrC8alkyl or C2-C5alkenyl, preferably H or Cj-Cgalkyl, to form compounds of formula I wherein X is S, or d) for the preparation of a compound of formula I wherein X is S and R3 is -SR, wherein R is CrC8alkyl, C3-C6cycloalkyl, C2-C8alkenyl or C2-C8alkynyl, preferably CrC8alkyl or C3-C6cycloalkyl, especially CrC8alkyl, a compound of formula n is reacted, if desired in the presence of a base, with CS2, and the intermediate, which is optionally isolated, is reacted, if desired in the presence of a base, with a compound of formula RY4, wherein R is as defined above and Y4 is a leaving group, or e) for the preparation of a compound of formula I wherein X is O, a compound of formula II is reacted, if desired in the presence of a base, with a compound of formula C1R8C0Y5, wherein Rg is as defined for formula I and Y5 is a leaving group, and the resulting intermediate is reacted, if desired in the presence of a base, optionally in the presence of an alkali metal halide, such as in the presence of sodium iodide, with a compound of formula <br><br>
270235 <br><br>
- 13- <br><br>
RgCOOH, HNR10Rn or R12, wherein Rg, R10, Rn and R12 are as defined for formula I, or f) for the preparation of a compound of formula I wherein X is S, a compound of formula which is known or can be prepared analogously to corresponding known compounds, for example in accordance with Variant b), and wherein m, n, Rlf R2, R3, R4 and R17 are as defined for formula I, is reacted with P2S5, or g) for the preparation of a compound of formula I wherein X is S and R2 is H, a compound of formula which is known or can be prepared analogously to corresponding known compounds and wherein m, n, Rlf R3, R4 and R17 are as defined for formula I, is reacted, if desired in the presence of a base, with H2S, or h) a compound of formula I wherein R2 is H is reacted, if desired in the presence of a base, with a compound of formula R2Y6, wherein R2 is as defined for formula I with the exception of the meaning H, and Y6 is a leaving group, or i) a compound of formula which is known or can be prepared analogously lo corresponding known compounds and <br><br>
(IV), <br><br>
O <br><br>
(V), <br><br>
2702 <br><br>
- 14- <br><br>
wherein m, n, Rj, R4 and R17 are as defined for formula I, is reacted, if desired in the presence of an acid catalyst, if desired in the presence of a water-binding agent, with a compound of formula which is known or can be prepared analogously to corresponding known compounds and wherein R2, R3 and X are as defined for formula I, or with a salt thereof and/or, as the case may be, with a tautomer thereof, <br><br>
and in each case, if desired, a compound of formula I or a tautomer thereof obtainable according to the process or by other means, in each case in free form or in salt form, is converted into a different compound of formula I or a tautomer thereof, a mixture of isomers obtainable according to the process is separated and the desired isomer is isolated and/or a free compound of formula I or a tautomer thereof obtainable according to the process is converted into a salt, or a salt of a compound of formula I or of a tautomer thereof obtainable according to the process is converted into the free compound of formula I or a tautomer thereof or into a different salt <br><br>
The remarks made above regarding tautomers and salts of compounds I apply analogously to starting materials mentioned hereinbefore and hereinafter with regard to their tautomers and salts. <br><br>
The reactions described hereinbefore and hereinafter are carried out in a manner known perse, for example in the absence or, customarily, in the presence of a suitable solvent or diluent or of a mixture thereof, the reactions being performed as necessary with cooling, at room temperature or with heating, for example in a temperature range of approximately from -80°C to the boiling temperature of the reaction medium, preferably from approximately -20°C to approximately +150°C, and, if necessary, in a closed vessel, under pressure, in an inert gas atmosphere and/or under anhydrous conditions. Especially advantageous reaction conditions are to be found in the Examples. <br><br>
The starting materials mentioned hereinbefore and hereinafter which are used for the preparation of the compounds I and, as the case may be, their tautomers, in each case in free form or in salt form, are known or can be prepared by methods known per se, for example in accordance with the details given below. <br><br>
H2N <br><br>
X <br><br>
(VI), <br><br>
- 15- <br><br>
Variant a): <br><br>
Suitable bases for facilitating the reaction are, for example, alkylamines, alkylene-diamines, unsubstituted or N-alkylated, saturated or unsaturated cycloalkylaraines, and basic heterocycles. There may be mentioned by way of example triethylamine, diiso-propylethylamine, triethylenediamine, N-cyclohexyl-N^N-dimethylamine, N,N-diethyl-aniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine and l,5-diazabicyclo[5.4.0]undec-5-ene (DBU). <br><br>
The reactants can be reacted with each other as such, that is to say without the addition of a solvent or diluent, for example in the melt. In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; amides, such as N,N-dimethylformamide, N,N-diethylform amide, N,N-dimethylacet-amide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. If the reaction is carried out in the presence of a base, bases used in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also serve as solvents or diluents. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately -20°C to approximately +20°C. <br><br>
In a preferred form of Variant a), a compound II is reacted with phosgene at from -20° to 0°, preferably -10°, in an aromatic hydrocarbon, preferably in toluene, and in the presence of a sulfonic acid as catalyst, preferably in the presence of triethylamine, and the product is isolated and further reacted with Y ,H. <br><br>
Variant b): <br><br>
Suitable leaving groups arc, for example, halogens, C,-C8alkoxy or Cj-Qalkylcarboxy, <br><br>
- 16- <br><br>
preferably halogens, especially chlorine. <br><br>
Suitable bases for facilitating the reaction are, for example, alkylamines, alkylene-diamines, unsubstituted or N-alkylated, saturated or unsaturated cycloalkylamines, and basic heterocycles. There may be mentioned by way of example triethylamine, diiso-propylethylamine, triethylenediamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethyl-aniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine and l,5-diazabicyclo[5.4.0]undec-5-ene (DBU). <br><br>
The reactants can be reacted with each other as such, that is to say without the addition of a solvent or diluent, for example in the melt. In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; amides, such as N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethylacet-amide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. If the reaction is carried out in the presence of a base, bases used in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also serve as solvents or diluents. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately -10°C to approximately +20°C. <br><br>
In a preferred form of Variant b), a compound II is reacted with one of the mentioned acylating agents at from -20° to 0°, preferably 0°, in an ether, preferably in diethyl ether. <br><br>
Variant c): <br><br>
The reactants can be reacted with each other as such, that is lo say without the addition of a solvent or diluent, for example in the melt. In mosl cases, however, the addition of an <br><br>
- 17- <br><br>
inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, broinobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; alcohols, such as methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol or glycerol; amides, such as N,N-dimethylformamide, N,N-diethylformamide, N,N-di-methylacetamide, N-niethylpyrrolidone or hexamethylphosphoric acid triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately -10°C to approximately +20°C. <br><br>
Variant d): <br><br>
Suitable leaving groups are, for example, halogens or CpCgalkylsulfates, preferably halogens, especially bromine or iodine, most especially iodine. <br><br>
Suitable bases for facilitating the reaction are, for example, alkali metal or alkaline earth metal hydroxides, hydrides, amides, alkanolates, acetates, carbonates, dialkylamides or alkylsilylamides, alkylamines, alkylenediamines, unsubstituted or N-alkylated, saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbo-cyclic amines. There may be mentioned by way of example sodium hydroxide, hydride, amide, methanolate, acetate or carbonate, potassium tert-butanolate, hydroxide, carbonate or hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)-pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and l,5-diazabicyclo[5.4.0]undec-5-ene (DBU). Especially suitable bases are alkali metal or alkaline earth metal hydrides, most especially alkali metal hydrides. <br><br>
The reaclanls can be reacicd with each other as such, that is lo say without ihe addition of <br><br>
-18- <br><br>
a solvent or diluent, for example in the melt. In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; amides, such as N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethyl-acetamide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. If the reaction is carried out in the presence of a base, bases used in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also serve as solvents or diluents. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately -10°C to approximately +20°C. <br><br>
In a preferred form of Variant d), a compound II is reacted at from -20° to 0°, preferably 0°, with CS2 in the presence of an alkali metal hydride, preferably sodium hydride, in a carboxylic acid amide, preferably in dimethylformamide, and then, without isolation of the intermediate, with one of the mentioned alkylating agents. <br><br>
Variant e): <br><br>
Suitable leaving groups are, for example, halogens or C1-C8alkoxy, preferably halogens, especially chlorine. <br><br>
Suitable bases for facilitating the reaction are, for example, alkylamines, alkylene-diamines, unsubstituted or N-alkylated, saturated or unsaturated cycloalkylamines, and basic heterocycles. There may be mentioned by way of example triethylamine, diiso-propylethylamine, triethylenediamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethyl-aniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine and 1,5-diazabicyclo[5.4.0]undec-5-ene (DBU). <br><br>
2702 <br><br>
-19- <br><br>
35 <br><br>
The reactants can be reacted with each other as such, that is to say without the addition of a solvent or diluent, for example in the melt In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic. hydrocarbons and halogena^d hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone cr methyl isobutyl ketone; amides, such as N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethyl-acetamide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. If the reaction is carried out in the presence of a base, bases used in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also serve as solvents or diluents. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately 0°C to approximately +90°C. <br><br>
In a preferred form of Variant e), a compound II is reacted, at from -20° to 20°, preferably 20°, in the presence of a base, preferably pyridine, in a halogen-containing hydrocarbon, preferably in methylene chloride, with one of the acylating agents mentioned in Variant e) and then with one of the nucleophilic reagents mentioned in Variant d). <br><br>
Variant f): <br><br>
The reactants can be reacted with each other as such, that is to say without the addition of a solvent or diluent, for example in the melt. In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether. <br><br>
-20- <br><br>
ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; and sulfoxides, such as dimethyl sulfoxide. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately -10°C to approximately <br><br>
+20°C. <br><br>
In a preferred form of Variant f), a compound II is reacted at from -20° to 0°, preferably 0°, with CS2 in the presence of a base, preferably sodium hydride, in a carboxylic acid amide, preferably in dimethylformamide, and then with an alkylating agent. <br><br>
Variant g): <br><br>
Suitable bases for facilitating the reaction are, for example, alkylamines, alkylene-diamines, unsubstituted or N-alkylated, saturated or unsaturated cycloalkylamines, and basic heterocycles. There may be mentioned by way of example triethylamine, diiso-propylethylamine, triethylenediamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethyl-aniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine and 1,5-diazabicyclo[5.4.0]undec-5-ene (DBU). <br><br>
The reactants can be reacted with each other as such, that is to say without the addition of a solvent or diluent, for example in the melt. In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; amides, such as N,N-dimethylformamide, N,N-diethylformamide, N,N-dimethyl-acetamide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. If the reaction is carried out in the presence of a base, bases used in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also serve as solvents or diluents. <br><br>
-21 - <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately 0°C to approximately +50°C. <br><br>
In a preferred form of Variant g), a compound IV is reacted with H2S at from -20° to 20°, preferably 20°, in the presence of a base, preferably triethylamine, in an ether, preferably in tetrahydrofuran. <br><br>
Variant h): <br><br>
Suitable leaving groups are, for example, halogens or CrC8alkylsulfates, preferably halogens, especially bromine or iodine, most especially iodine. <br><br>
Suitable bases for facilitating the reaction are, for example, alkali metal or alkaline earth metal hydroxides, hydrides, amides, alkanolates, acetates, carbonates, dialkylamides or alkylsilylamides, alkylamines, alkylenediamines, unsubstituted or N-alkylated, saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbo-cyclic amines. There may be mentioned by way of example sodium hydroxide, hydride, amide, methanolate, acetate or carbonate, potassium tert-butanolate, hydroxide, carbonate or hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)-pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and l,5-diazabicyclo[5.4.0]undec-5-ene (DBU). <br><br>
The reactants can be reacted with each other as such, that is to say without the addition of a solvent or diluent, for example in the melt. In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; alcohols, such as methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol or <br><br>
-22- <br><br>
glycerol; amides, such as N,N-dimethylformamide, N,N-diethylformamide, N,N-di-methylacetamide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; nitrites, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. If the reaction is carried out in the presence of a base, bases used in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also serve as solvents or diluents. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately 0°C to approximately +90°C. <br><br>
Variant i): <br><br>
Suitable acid catalysts for facilitating the reaction are, for example, sulfonic acids, such as methane- or p-toluene-sulfonic acid, camphor- 10-sulfonic acid, pyridinio-p-toluene-sulfonate, including the acidic ion-exchange resins with sulfo groups, Lewis acids, such as boron trifluoride diethyl ether or dimethyl ether complexes, and mineral acids, such as sulfuric acid or phosphoric acid. <br><br>
Suitable water-binding agents for facilitating the removal of water are, for example, carbodiimides, such as N,N'-dicyclohexylcarbodiimide, or l-alkyl-2-halo-pyridinium salts, such as l-methyl-2-chloro-pyridinium iodide. <br><br>
The reactants can be reacted with each other as such, that is to say without the addition of a solvent or diluent, for example in the melt. In most cases, however, the addition of an inert solvent or diluent or of a mixture thereof is advantageous. Examples of such solvents or diluents are: aromatic, aliphatic and alicyclic hydrocarbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichloro-benzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, tri-chloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters, such as ethyl acetate; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy diethyl ether, tetrahydrofuran or dioxane; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; alcohols, such as methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol or glycerol; amides, such as N.N-dimclhylformamide, N,N-dieihylformamide, N,N-di-methylacetamide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; nitriles, <br><br>
23 <br><br>
270255 <br><br>
such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide. If the reaction is carried out in the presence of an acid catalyst, acids used in excess, for example strong organic carboxylic acids, such as unsubstituted or substituted, for example halo-substituted, C1-C4alkanecarboxylic acids, for example formic acid, acetic acid or propionic acid, may also serve as solvents or diluents. <br><br>
The reaction is advantageously carried out in a temperature range of from approximately -30°C to approximately +100°C, preferably from approximately 0°C to approximately +90°C. <br><br>
Salts of compounds I can be prepared in a manner known per se. For example, acid addition salts of compounds I are obtained by treatment with a suitable acid or a suitable ion-exchange reagent, and salts with bases are obtained by treatment with a suitable base or a suitable ion-exchange reagent. <br><br>
Salts of compounds I can be converted into free compounds I in customary manner: acid addition salts, for example, by treatment with a suitable basic agent or a suitable ion-exchange reagent, and salts with bases, for example, by treatment with a suitable acid or a suitable ion-exchange reagent <br><br>
Salts of compounds I can be converted into different salts of compounds I in a manner known per se: acid addition salts, for example, can be converted into different acid addition salts, for example by treatment of a salt of an inorganic acid, such as a hydrochloride, with a suitable metal salt, such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt being formed, for example silver chloride, is insoluble and therefore separates from the reaction mixture. <br><br>
Depending upon the procedure and the reaction conditions, compounds I having salt-forming properties can be obtained in free form or in the form of salts. <br><br>
The compounds I, II, III and IV may be in the form of one of the possible isomers or in the form of a mixture thereof; for example, depending upon the number and the absolute and relative configuration of the asymmetric carbon atoms, they may be in the form of pure isomers, such as antipodes and/or diastereoisomers, or in the form of mixtures of isomers, such as mixtures of enantiomers, for example racemates, mixtures of diastereoisomers or mixtures of racemates; the invention relates both to the pure isomers and to all possible <br><br>
-24- <br><br>
270 2 <br><br>
mixtures of isomers and this is to be understood hereinbefore and hereinafter, even if stereochemical details are not specifically mentioned in every case. <br><br>
Mixtures of diastereoisomers and mixtures of racemates of compounds I, II, III and IV that are obtainable in accordance with the process - depending upon the starting materials and procedures chosen, - or by other means, can be separated into the pure diastereoisomers or racemates in known manner on the basis of the physico-chemical differences between the constituents, for example by fractional crystallisation, distillation and/or chromatography. <br><br>
Mixtures of enantiomers, such as racemates, accordingly obtainable can be separated into the optical antipodes by known methods, for example by recrystallisation from an optically active solvent, by chromatography on chiral adsorbents, for example high-pressure liquid chromatography (HPLC) on acetylcellulose, with the aid of suitable microorganisms, by cleavage with specific immobilised enzymes, or via the formation of inclusion compounds, for example using chiral crown ethers, in which case only one enantiomer is complexed. <br><br>
Apart from by the separation of corresponding mixtures of isomers, it is possible according to the invention to obtain pure diastereoisomers or enantiomers also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process of the invention with starting materials having correspondingly suitable stereochemistry. <br><br>
Advantageously, the biologically more active isomer, for example enantiomer, or mixture of isomers, for example mixture of enantiomers, will be isolated or synthesised, insofar as the individual components have differing biological activity. <br><br>
The compounds I, II, III and IV can also be obtained in the form of their hydrates and/or may include other solvents, for example solvents that have been used, where appropriate, for the crystallisation of compounds that are in solid form. <br><br>
The invention relates to all those forms of the process according to which a compound obtainable as starting material or intermediate at any stage of the process is used as starting material and all or some of the remaining steps are carried out, or a starting material is used in the form of a derivative or a salt and/or its racemates or antipodes or, especially, is formed under the reaction conditions. <br><br>
-25- <br><br>
270 <br><br>
The starting materials and intermediates used in the process of the present invention are preferably those which result, in the compounds I described at the beginning as being especially valuable. <br><br>
The invention relates especially to the preparation processes described in Examples PI to P17. <br><br>
The invention relates also to those starting materials and intermediates used according to the invention for the preparation of the compounds I or the salts thereof, in each case in free form or in salt form, that are novel, to the use thereof and to processes for the preparation thereof. <br><br>
The compounds I according to the invention are valuable active ingredients in the area of pest control while being well tolerated by warm-blooded animals, fish and plants. In particular, the compounds according to the invention are effective against insects of the type occurring on useful plants and ornamentals in agriculture and in horticulture, especially in cotton, vegetable or fruit crops, and in forestry. The compounds according to the invention are especially suitable for the control of insects in fruit and vegetable crops, especially of phytopathogenic insects, such as Spodoptera littoralis, Heliothis virescens, Diabrotica balteata and Crocidolomia binotalis. Further areas of use of the compounds according to the invention are the protection of stored goods and material stocks, and also in the hygiene sector, especially the protection of domestic animals and productive livestock. The compounds of the invention are effective against all or individual development stages of normally sensitive and also resistant types of pest. Their action may manifest itself, for example, in mortality of the pests, which occurs immediately or only at a later date, for example during moulting, or in reduced oviposition and/or a reduced hatching rate. <br><br>
The above-mentioned pests include: <br><br>
of the order Lepidoptera, for example <br><br>
Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Anticarsia gemmatalis, Archips spp., Argyrotaenia spp., Autographa spp., Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo spp., Choristoneura spp., Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Crocidolomia binotalis, Cryptophlebia leucotreta, Cydia spp., Diatraea spp., Diparopsis <br><br>
27 <br><br>
i> <br><br>
0 <br><br>
-26 <br><br>
castanea, Earias spp., Ephestia spp., Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Grapholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Hyphantria cunea, Keiferia lycopersicella, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Operophtera spp., Ostrinia nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Pectinophora gossypiella, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Scirpophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusia ni and Yponomeuta spp.; <br><br>
of the order Coleoptera, for example <br><br>
Agriotes spp., Anthonomus spp., Atomaria linearis, Chaetocnema tibialis, Cosmopolites spp., Curculio spp., Dermestes spp., Diabrotica spp., Epilachna spp., Eremnus spp., Leptinotarsa decemlineata, Lissorhoptrus spp., Melolontha spp., Orycaephilus spp., Otiorhynchus spp., Phlyctinus spp., Popillia spp., Psylliodes spp., Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Tenebrio spp., Tribolium spp. and Trogoderma spp.; <br><br>
of the order Orthoptera, for example <br><br>
Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., <br><br>
Periplaneta spp. and Schistocerca spp.; <br><br>
of the order Isoptera, for example <br><br>
Reticulitermes spp.; <br><br>
of the order Psocoptera, for example <br><br>
Liposcelis spp.; <br><br>
of the order Anoplura, for example <br><br>
Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.; <br><br>
of the order Mallophaga, for example Damalinea spp. and Trichodectes spp.; <br><br>
of the order Thysanoptera, for example <br><br>
Frankliniella spp., Hercinothrips spp., Taeniothrips spp., Thrips palmi, Thrips tabaci and <br><br>
Scirtothrips aurantii; <br><br>
of the order Heteroptera, for example <br><br>
Cimex spp., Distantiella theobroma, Dysdercus spp., Euchistus spp., Eurygaster spp., Leptocorisa spp., Nezara spp., Piesma spp., Rhodnius spp., Sahlbergella singular;* Scotinophara spp. and Triatoma spp.; <br><br>
of the order Homoptera, for example <br><br>
27 <br><br>
- 27 - <br><br>
Aleurothrixus floccosus, Aleyrodes brassicae, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Bemisia tabaci, Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Coccus hesperidum, Empoasca spp., Eriosoma larigerum, Erythroneura spp., Gascardia spp., Laodelphax spp., Lecanium corni, Lepidosaphes spp., Macrosiphus spp., Myzus spp., Nephotettix spp., Nilaparvata spp., Paratoria spp., Pemphigus spp., Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Rhopalosiphum spp., Saissetia spp., Scaphoideus spp., Schizaphis spp., Sitobion spp., Trialeurodes vaporariorum, Trioza erytreae and Unaspis citri; <br><br>
of the order Hymenoptera, for example <br><br>
Acromyrmex, Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplocampa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Solenopsis spp. and Vespa spp.; <br><br>
of the order Diptera, for example <br><br>
Aedes spp., Antherigona soccata, Bibio hortulanus, Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Drosophila melanogaster, Fannia spp., Gastrophilus spp., Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis pomonella, Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.; <br><br>
of the order Siphonaptera, for example Ceratophyllus spp. and Xenopsylla cheopis and of the order Thysanura, for example Lepisma saccharina. <br><br>
The good pesticidal activity of the compounds of the invention corresponds to a mortality of at least 50 to 60 % of the mentioned pests. <br><br>
The activity of the compounds according to the invention and of the compositions comprising them can be substantially broadened and adapted to prevailing circumstances by the addition of other insecticides. Examples of suitable additives are representatives of the following classes of compounds: organophosphorus compounds, nitrophenols and derivatives thereof, formamidines, ureas, carbamates, pyrethroids, chlorinated hydrocarbons and Bacillus thuringiensis preparations. <br><br>
The compounds according to the invention are used in unmodified form or, preferably. <br><br>
27 <br><br>
-28 <br><br>
together with the adjuvants customarily employed in formulation technology and can therefore be formulated in known manner e.g. into emulsifiable concentrates, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and also encapsulations in polymer substances. As with the nature of the compositions, the methods of application, such as spraying, atomising, dusting, scattering or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. <br><br>
The formulations, i.e. the compositions, preparations or mixtures comprising the compound (active ingredient) of the invention or a combination thereof with other insecticides, and, where appropriate, solid or liquid adjuvants, are prepared in known manner, e.g. by homogeneously mixing and/or grinding the active ingredient with the adjuvants, such as extenders, e.g. solvents or solid carriers, or surface-active compounds (surfactants). <br><br>
Suitable solvents are: aromatic hydrocarbons, preferably alkylbenzene fractions containing 8 to 12 carbon atoms, such as xylene mixtures or alkylated naphthalenes, aliphatic or cycloaliphatic hydrocarbons, such as cyclohexane, paraffins or tetrahydronaphthalene, alcohols, such as ethanol, propanol or butanol, glycols and their ethers and esters, such as propylene glycol, dipropylene glycol ether, ethylene glycol, ethylene glycol monomethyl or monoethyl ether, ketones, such as cyclohexanone, isophorone or diacetanol alcohol, strongly polar solvents, such N-methyl-2-pyrrolidone, dimethyl sulfoxide or N,N-di-methylformamide, water and vegetable oils or epoxidised vegetable oils, such as rape oil, castor oil, coconut oil or soybean oil or epoxidised rape oil, castor oil, coconut oil or soybean oil; and, where appropriate, silicone oils. <br><br>
The solid carriers used, e.g. for dusts and dispersible powders, are normally natural mineral fillers such as calcite, talcum, kaolin, montmorillonite or attapulgite. In order to improve the physical properties it is also possible to add highly dispersed silicic acids or highly dispersed absorbent polymers. Suitable granulated adsorptive carriers are porous types, such as pumice, broken brick, sepiolite or bentonite; and suitable nonsorbent carriers are calcite or sand. In addition, a great number of granulated materials of inorganic or organic nature can be used, especially dolomite or pulverised plant residues. <br><br>
Depending upon the nature of the compound of the invention or of the combination of that compound with other insecticides which is to be formulated, suitable surface-active <br><br>
2 <br><br>
/ <br><br>
-29- <br><br>
compounds are non-ionic, cationic and/or anionic surfactants having good emulsifying, dispersing and wetting properties. The term "surfactants" will also be understood as comprising mixtures of surfactants. <br><br>
Non-ionic surfactants are preferably polyglycol ether derivatives of aliphatic or cyclo-aliphatic alcohols, saturated or unsaturated fatty acids and alkylphenols, said derivatives containing 3 to 30 glycol ether groups and 8 to 20 carbon atoms in the (aliphatic) hydrocarbon moiety and 6 to 18 carbon atoms in the alkyl moiety of the alkylphenols. Further suitable non-ionic surfactants are water-soluble adducts of polyethylene oxide with polypropylene glycol, ethylenediaminopolypropylene glycol and alkylpolypropylene glycol containing 1 to 10 carbon atoms in the alkyl chain, which adducts contain 20 to 250 ethylene glycol ether groups and 10 to 100 propylene glycol ether groups. These compounds usually contain 1 to 5 ethylene glycol units per propylene glycol unit Representative examples of non-ionic surfactants are nonylphenol polyethoxyethanols, castor oil polyglycol ethers, polypropylene/polyethylene oxide adducts, tributylphenoxypolyethoxy-ethanol, polyethylene glycol and octylphenoxypolyethoxyethanol. Fatty acid esters of polyoxyethylene sorbitan, e.g. polyoxyethylene sorbitan trioleate, are also suitable non-ionic surfactants. <br><br>
Cationic surfactants are preferably quaternary ammonium salts which contain, as N-substituent, at least one C8-C22alkyl radical and, as further substituents, unsubstituted or halogenated lower alkyl, benzyl or hydroxy-lower alkyl radicals. The salts are preferably in the form of halides, methyl sulfates or ethyl sulfates. Examples are stearyltrimethyl-ammonium chloride and benzyldi(2-chloroethyl)ethylammonium bromide. <br><br>
Both so-called water-soluble soaps and water-soluble synthetic surface-active compounds are suitable anionic surfactants. Suitable soaps are the alkali metal salts, alkaline earth metal salts or unsubstituted or substituted ammonium salts of higher fatty acids (C^-C^). e.g. the sodium or potassium salts of oleic or stearic acid or of natural fatty acid mixtures which can be obtained e.g. from coconut oil or tall oil; mention may also be made of fatty acid methyltaurin salts. More frequently, however, so-called synthetic surfactants are used, especially fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or alkylarylsulfonates. The fatty sulfonates or sulfates are usually in the form of alkali metal salts, alkaline earth metal salts or unsubstituted or substituted ammonium salts and generally contain a C8-C22alkyl radical, which also includes the alkyl moiety of acyl radicals; there may be mentioned by way of example the sodium or calcium salt of ligno- <br><br>
-30- <br><br>
sulfonic acid, of dodecyl sulfate or of a mixture of fatty alcohol sulfates obtained from natural fatty acids. These compounds also comprise the salts of sulfated or sulfonated fatty alcohol/ethylene oxide adducts. The sulfonated benzimidazole derivatives preferably contain 2 sulfonic acid groups and one fatty acid radical containing approximately 8 to 22 carbon atoms. Examples of alkylarylsulfonates are the sodium, calcium or triethanol-ammonium salts of dodecylbenzenesulfonic acid, dibutylnaphthalenesulfonic acid or of a condensate of naphthalenesulfonic acid and formaldehyde. Also suitable are corresponding phosphates, e.g. salts of the phosphoric acid ester of an adduct of p-nonylphenol with 4 to 14 mol of ethylene oxide, or phospholipids. <br><br>
The surfactants listed above are to be regarded merely as examples; many more surfactants customarily employed in formulation technology and suitable for use according to the invention are described in the relevant literature. <br><br>
The pesticidal compositions usually comprise 0.1 to 99 %, preferably 0.1 to 95 %, of a compound of the invention or of a combination of that compound with other insecticides, and 1 to 99.9 %, preferably 5 to 99.9 %, of a solid or liquid adjuvant, it generally being possible for 0 to 25 %, preferably 0.1 to 20 %, of the composition to be surfactants (percentages are by weight in each case). Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations which have considerably lower active ingredient concentrations. Typical concentration rates are from 0.1 to 1000 ppm, preferably from 0.1 to 500 ppm, active ingredient The application rates per hectare are generally from 1 to 1000 g of active ingredient per hectare, preferably from 25 to 500 g/ha. <br><br>
Preferred formulations have especially the following composition (throughout percentages are by weight): <br><br>
Emulsifiable concentrates: active ingredient: surfactant: <br><br>
liquid carrier: <br><br>
1 to 90 %, preferably 5 to 20 % 1 to 30 %, preferably 10 to 20 % 5 to 94 %, preferably 70 to 85 % <br><br>
Dusts: <br><br>
active ingredient: solid carrier: <br><br>
0.1 to 10 %, preferably 0.1 lo 1 % 99.9 to 90 %, preferably 99.9 to 99 % <br><br>
2 <br><br>
-31 - <br><br>
Suspension concentrates: active ingredient: <br><br>
water: <br><br>
surfactant: <br><br>
5 to 75 %, preferably 10 to 50 % 94 to 24 %, preferably 88 to 30 % 1 to 40 %, preferably 2 to 30 % <br><br>
Wettable powders: active ingredient: surfactant: <br><br>
solid carrier: <br><br>
0.5 to 90 %, preferably 1 to 80 % 0.5 to 20 %, preferably 1 to 15 % 5 to 95 %, preferably 15 to 90 % <br><br>
Granules: <br><br>
active ingredient: solid carrier: <br><br>
0.5 to 30 %, preferably 3 to 15 % 99.5 to 70 %, preferably 97 to 85 % <br><br>
The compositions may also comprise other adjuvants, such as stabilisers, e.g. vegetable oils or epoxidised vegetable oils (e.g. epoxidised coconut oil, rape oil or soybean oil), antifoams, e.g. silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, as well as fertilisers or other active ingredients for obtaining special effects. <br><br>
The following Examples serve to illustrate the invention. They do not limit the invention. Temperatures are given in degrees Celsius. <br><br>
Preparation Examples <br><br>
General Remarks <br><br>
The compounds are obtained as isomeric mixtures usually in the form of viscous oils. <br><br>
They can be purified by column chromatography. NMR spectra and elemental analyses confirm the required structures. <br><br>
Example PI: 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-methylhydrazone 180 g of 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone are heated under reflux in 600 ml of absolute alcohol with 29.6 g of glacial acetic acid and 31.8 g of methyl-hydrazine for one day. The solution is then concentrated by evaporation in vacuo, and the residue is taken up in approximately 150 ml of toluene and again concentrated by evaporation. The oil which remains is taken up in hexane/cthyl acetatc 9:1 and the solution is <br><br>
270 <br><br>
-32- <br><br>
stirred over magnesium sulfate and sodium bicarbonate for approximately 30 minutes. The salts are removed by filtration and the filtrate is concentrated by evaporation in vacuo. The title compound remains behind in the form of a yellow oil. <br><br>
Example P2: 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-formvl-N-methvl-hydrazone (compound 1.1 in Table 1) <br><br>
With the exclusion of moisture, 150 g of sodium formate are introduced into approximately 125 ml of ether with stirring, and 147 g (1.87 mol) of acetyl chloride are added dropwise thereto at a reaction temperature of 0°C. The reaction mixture is then stirred for several hours at room temperature, sodium chloride is removed by filtration, and the residue is washed with dry ether to yield a solution of approximately 1.87 mol of formyl acetate in ether. <br><br>
A portion of that solution, containing 0.49 mol of formyl acetate, is added dropwise to a solution of 184 g of the hydrazone from Example PI in 200 ml of ether. The reaction is complete after a few hours. Ice-water is added, the organic layer is collected, washed once more with water, dried over magnesium sulfate and filtered, and the filtrate is concentrated by evaporation and purified by column chromatography on silica gel using ethyl acetate/hexane 1:9 as eluanL The product is obtained as an isomeric mixture in the form of an oily-waxy mass. <br><br>
Example P3: 4-chloro-4'-trifluoromethanesulfonyloxvbenzophenone-N-acetvl-N-formvl-hydrazone (compound 1.2 in Table 1) <br><br>
4.05 g of 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-formylhydrazone are stirred in 30 ml of dry tetrahydrofuran with 0.7 ml of acetyl chloride and 1.4 ml of triethylamine and, after 20 hours, the reaction solution is concentrated by evaporation and the residue is chromatographed on a column of silica gel using ethyl acetate/hexane 1:5 as eluant. The title compound is obtained as an isomeric mixture having a melting point of 137-142°C. <br><br>
Example P4: 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-chlorocarbonyl-N-methylhydrazone <br><br>
At -10°C, a solution of 40.5 g of the hydrazone from Example PI and 10.1 g of triethylamine in 100 ml of ethyl acetate are added dropwise to 57 ml of 0.11M phosgene solution in toluene. After approximately 1 hour, the reaction solution is filtered and washed with a small amount of ethyl acetalc, the filtrate is concentrated by evaporation in vacuo, and the <br><br>
27023 <br><br>
-33- <br><br>
residue is purified on a column of silica gel using ethyl acetate/hexane 1:9 as eluant. The product is obtained in the form of a sticky crystalline mass. <br><br>
Example P5:4-chloro-4'-trifluoromethanesulfonvloxybenzophenone-N-methyl-N-methvl-aminocarbonylhydrazone (compound 1.3 in Table 1) <br><br>
0.025 mol of methylamine (33 % in absolute alcohol) is added all at once to 0.01 mol of the carbamoyl chloride from Example P4 in the form of a crude solution in ethyl acetate. After 15 minutes, the reaction mixture is poured onto ice-water, and the organic layer is separated off and, after being dried over magnesium sulfate, is concentrated by evaporation in vacuo. Purification by column chromatography on silica gel using ethyl acetate/-hexane (1:2) as eluant yields the title compound having a melting point of 112-116°C. <br><br>
Example F6: 4-chloro-4'-trifluoromethanesulfonvloxybenzophenone-N-methvl-N-thio-methylcarbonylhydrazone (compound 1.4 in Table 1) <br><br>
0.02 mol of the carbamoyl chloride from Example P4 in ethyl acetate solution is stirred overnight with 1.5 g of sodium methylmercaptide; working-up yields the title compound in the form of a viscous yellowish oil. <br><br>
Example P7:4-chloro-4'-trifluoromethanesulfonvloxvbenzophenone-N-methvlthiomethvl-carbonylhydrazone (compound 1.126 in Table 1) <br><br>
0.065 mol of a solution of triethylammonium hydrogen sulfide in tetrahydrofuran (prepared beforehand by passing 34 g of hydrogen sulfide into a solution of 101 g of triethylamine in tetrahydrofuran) is added to 2.55 g of 4-chloro-4'-trifluoromethane-sulfonyloxybenzophenone-N-(l-chloro)-ethylidenehydrazone in 20 ml of tetrahydrofuran. The reaction mixture is then stirred for a few hours and is concentrated by evaporation, and the residue is chromatographed on silica gel using ethyl acetate/hexane 1:9 as eluant, to yield an isomeric mixture of the title compound in the form of a thick yellowish oil. <br><br>
Exam pie P8: 4-chloro-4'-trifluoromethanesulfonyloxvbenzophenone-N.N-dimethvlamino-thiocarbonyl-N-methylhydrazone (compound 1.127 in Table 1) <br><br>
Analogously to Example P4, but using thiophosgene instead of phosgene, a yellow solution of 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-methyl-N-chloro-thiocarbamoylhydrazone in ethyl acetate is prepared. To an aliquot of that solution, containing 0.023 mol of the thiocarbamoyl chloride, there are added 6.5 g of 33 % dimethylamine solution in absolute alcohol. After three hours, ice-waler is added and the organic layer is separated olT, dried and concentrated by evaporation. The residue is <br><br>
270 <br><br>
-34- <br><br>
purified on a column of silica gel using ethyl acetate/hexane 1:9 as eluant. The title compound is obtained in the form of a viscous yellow oil. <br><br>
Example P9: 4-chloro-4'-trifluoromethanesulfonyloxvbenzophenone-N-methyl-N-thio-formylhydrazone (compound 1.128 in Table 1) <br><br>
3.6 g of the compound from Example P2 are stirred with 1.9 g of phosphorus pentasulfide in 30 ml of toluene for 20 hours. For working up, ice-water and sodium bicarbonate are added, extraction is carried out with ethyl acetate, the organic phase is dried and concentrated by evaporation in vacuo and the residue is chromatographed using ethyl acetate/-hexane 1:9. The title compound is obtained in the form of an orange-coloured oil. <br><br>
ExamplePIO: 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-methyl-N-methylthiothiocarbonylhydrazone (compound 1.129 in Table 1) <br><br>
7.1 g of the compound from Example PI are introduced into a mixture of 25 ml of dry dimethylformamide and 1.3 ml of carbon disulfide. At 0°C, 0.6 g of sodium hydride (80 % dispersion in oil) is added. After approximately 30 minutes, 1.3 ml of methyl iodide are added. After two hours, ice-water is added and extraction is carried out with ether. The organic phases are combined, dried and concentrated by evaporation, to yield a viscous oil which is purified on a column of silica gel using ethyl acetate/hexane 1:9. The title compound is obtained as an isomeric mixture having a melting point of 94-99°C. <br><br>
Example PI 1:4-chloro-4'-trifluoromethanesulfonvloxvbenzophenone-N-aminothio-carbonylhydrazone (compound 1.130 in Table 1) <br><br>
15 g of 4-chloro-4'-trifluoromethanesulfonyloxybenzophenonehydrazone are stirred with 3.5 g of ammonium thiocyanate in 100 ml of alcohol, and added dropwise to 4.5 g of methanesulfonic acid. The reaction mixture is then stirred for several hours until the starting material can no longer be detected in a thin-layer chromatogram. The product is precipitated by the addition of water. It is isolated by filtration, dried and recrystallised from ethyl acetate/hexane to yield the title compound having a melting point of 94-96°C. <br><br>
Example PI2: 4-fluoro-4'-trifluoromethanesulfonyloxvbenzophenone-N-isobutylidene-carbonyl-N-methylbenzophenone (compound 1.12 in Table 1) <br><br>
1.28 g of N-ethyl-diisopropylamine and 1.47 g of 3,3-dimethylacrylic acid chloride are added in succession to a solution of 3.38 g of 4-fluoro-4'-trifluoromethanesulfonyloxy-benzophenone-N-methylhydrazone (prepared analogously to the method described in Example PI) in 50 ml of tetrahydrofuran, and the reaction mixture is stirred at room <br><br>
-35- <br><br>
27^23 <br><br>
temperature for 15 hours. It is then concentrated by evaporation in vacuo. The residue is partitioned between dichloromethane and water. The organic phase is dried over sodium sulfate, filtered and concentrated by evaporation. The crude product is chromatographed on silica gel using hexane/ethyl acetate 10:1 to yield the title compound in the form of a yellow oil. <br><br>
Example P13: 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-methyl-N-(N'-methoxy-N'-methyl)aminocarbonylhydrazone (compound 1.5 in Table 1) <br><br>
0.91 g of triethylamine and 1.1 g of N-methyl-N-Piethoxycarbamoyl chloride are added in succession to a solution of 3.2 g of 4-chloro-4'-trifluoromethanesulfonyloxybenzo-phenone-N-methylhydrazone in 50 ml of toluene. After refluxing for 2 hours, the reaction mixture is cooled and concentrated by evaporation in vacuo. The residue is partitioned between ethyl acetate and water. The organic phase is dried over sodium sulfate, filtered and concentrated by evaporation. The crude product is chromatographed on silica gel using ethyl acetate/hexane 1:5 to yield the title compound in the form of a brownish oil. <br><br>
Example P14: 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-chloromethvl-carbonylhydrazone <br><br>
7.2 g of chloroacetyl chloride are added dropwise over a period of 30 minutes to a solution of 22 g of 4-chloro-4'-trifluoromethanesulfonyloxybenzophenonehydrazone and 5.5 g of pyridine in 100 ml of methylene chloride. The reaction mixture is stirred at room temperature for 16 hours, then poured onto 100 ml of water and extracted with 200 ml of methylene chloride. The organic phase is washed with saturated sodium chloride solution, dried with magnesium sulfate and concentrated by evaporation. The resulting crude product is purified by chromatography on silica gel using hexane/ethyl acetate 3:1 to yield the title compound in the form of a solid having a melting point of 123-125°C. <br><br>
Example P15: 4-chloro-4'-trifluoromethanesulfonyloxvbenzophenone-N-(6-chloro-6.6-difluoro-2-oxa-3-oxohexanecarbonyl)hydrazone (compound 1.78 in Table 1) <br><br>
A mixture of 3 g of the product from Example P14,0.1 g of sodium iodide, 1.0 g of 4-chloro-4,4-difluorobutyric acid and 0.67 g of triethylamine in 10 ml of DMF is heated at 90°C for 16 hours. The reaction mixture is then poured onto water and extracted with 100 ml of ethyl acetate. The organic phase is washed with saturated sodium chloride solution, dried with magnesium sulfate and concentrated by evaporation. The resulting crude product is purified by chromatography on silica gel using methylene chloride/2 % methanol to yield the title compound in the form of an amorphous solid. <br><br>
-36- <br><br>
270 <br><br>
Example PI6: 4-chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-(acetoxy-methylenecarbonyl)hydrazone (compound 1.77 in Table 1) <br><br>
A mixture of 4 g of the product from Example P14, 0.13 g of sodium iodide and 0.72 g of sodium acetate in 10 ml of DMF is heated at 50°C for 5 hours. The reaction mixture is then poured onto water and extracted with 100 ml of ethyl acetate. The organic phase is washed with saturated sodium chloride solution, dried with magnesium sulfate and concentrated by evaporation. The resulting residue is purified by chromatography on silica gel using hexane/ethyl acetate 1:1 to yield the title compound in the form of an amorphous solid. <br><br>
Example P17: 4-chloro-4l-trifluoromethanesulfonyloxybenzophenone-N-( 1-imidazolyl)-methylenecarbonylhydrazone (compound 1.80 in Table 1) <br><br>
A mixture of 3 g of the product from Example P14,0.1 g of sodium iodide, 0.45 g of imidazole and 0.66 g of triethylamine in 10 ml of DMF is heated at 50°C for 10 hours. The reaction mixture is then poured onto water and extracted with 100 ml of ethyl acetate. The organic phase is washed with saturated sodium chloride solution, dried with magnesium sulfate and concentrated by evaporation. The resulting crude product is purified by chromatography on silica gel using methylene chloride/methanol (1 %) to yield the title compound in the form of an amorphous solid. <br><br>
Example PI8: <br><br>
In a manner analogous to that described in Examples P2, P3, P5 to P13 and P15 to P17, it is also possible to prepare the other compounds listed in Tables 1 to 4. In the column "physic, data" of those Tables, the numbers indicate the melting point <br><br>
-37- <br><br>
2702Jf <br><br>
Table 1 <br><br>
0 "CF, <br><br>
comp. no. X Rt <br><br>
R, <br><br>
physic, data <br><br>
1.1 <br><br>
o ci ch3 <br><br>
h oil/wax <br><br>
1.2 <br><br>
o ci cho ch3 <br><br>
137-142° <br><br>
1.3 <br><br>
o ci ch3 <br><br>
nhch3 <br><br>
112-116° <br><br>
1.4 <br><br>
o ci ch3 <br><br>
sch3 <br><br>
oil <br><br>
1.5 <br><br>
o ci v"3 <br><br>
n(och3)ch3 <br><br>
resin <br><br>
1.6 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
n(och3)ch3 <br><br>
resin <br><br>
1.7 <br><br>
0 <br><br>
ci ch3 <br><br>
n(0c2hs)ch3 <br><br>
resin <br><br>
1.8 <br><br>
o ci ch3 <br><br>
n(oc2h5)c2h5 <br><br>
oil <br><br>
1.9 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
ch3 <br><br>
resin <br><br>
1.10 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
c2h5 <br><br>
0 <br><br>
t-h on i <br><br>
00 <br><br>
00 <br><br>
1.11 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
i-C3H7 <br><br>
resin <br><br>
1.12 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
ch=c(ch3)2 <br><br>
resin <br><br>
1.13 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
cyclo-C3H5 <br><br>
72-76° <br><br>
1.14 <br><br>
o ci ch3 <br><br>
cyclo-C3H5 <br><br>
80-82° <br><br>
1.15 <br><br>
o ci ch3 <br><br>
nhoc2h5 <br><br>
oil <br><br>
1.16 <br><br>
o ci ch3 <br><br>
nhoch2ch=ch2 <br><br>
oil <br><br>
1.17 <br><br>
o ci ch3 <br><br>
nh0ch2c(ch3)=ch2 <br><br>
oil <br><br>
1.18 <br><br>
o ci ch3 <br><br>
CH2-cyclo-C3H3F2(2,2) <br><br>
resin <br><br>
1.19 <br><br>
0 <br><br>
ci cho cf3 <br><br>
108-110° <br><br>
1.20 <br><br>
0 <br><br>
F <br><br>
ch3 <br><br>
CH2-cyclo-C3H3F2(2,2) <br><br>
resin <br><br>
1.21 <br><br>
0 <br><br>
ci ch3 <br><br>
nh2 <br><br>
118-126° <br><br>
1.22 <br><br>
0 <br><br>
ci ch3 <br><br>
ch3 <br><br>
80-82 <br><br>
1.23 <br><br>
0 <br><br>
ci ch3 <br><br>
ci oil <br><br>
1.24 <br><br>
o <br><br>
Br ch3 <br><br>
c2h5 <br><br>
1.25 <br><br>
o <br><br>
Br ch3 <br><br>
ch3 <br><br>
94-105° <br><br>
-38- <br><br>
1.26 <br><br>
0 <br><br>
Br ch3 <br><br>
n-C3H7 <br><br>
113-115° <br><br>
1.27 <br><br>
0 <br><br>
Br ch3 <br><br>
i-C3H7 <br><br>
honey <br><br>
1.28 <br><br>
0 <br><br>
Br ch3 <br><br>
CH(CH3)C2H5 <br><br>
oil <br><br>
1.29 <br><br>
0 <br><br>
Br ch3 <br><br>
cyclohexyl resin <br><br>
1.30 <br><br>
0 <br><br>
Br ch3 <br><br>
t-C4H9 <br><br>
resin <br><br>
1.31 <br><br>
0 <br><br>
Br ch3 <br><br>
n-C3H7 <br><br>
resin <br><br>
1.32 <br><br>
0 <br><br>
Br ch3 <br><br>
cyclo-C3H5 <br><br>
92-103° <br><br>
1.33 <br><br>
0 <br><br>
ci ch3 <br><br>
thien-2-yl amorphous <br><br>
1.34 <br><br>
0 <br><br>
ci ch3 <br><br>
thien-3-yl resin <br><br>
1.35 <br><br>
0 <br><br>
ci ch3 <br><br>
5-chlorothien-2-yl resin <br><br>
1.36 <br><br>
o ci ch3 <br><br>
3-chlorothien-2-yl <br><br>
1.37 <br><br>
0 <br><br>
ci ch3 <br><br>
benzo[b] thien-2-yl <br><br>
1.38 <br><br>
0 <br><br>
ci ch3 <br><br>
5-chlorobenzo[b]thien-2-yl <br><br>
1.39 <br><br>
0 <br><br>
ci ch3 <br><br>
3-chlorobenzo[b]thien-2-yl amorphous <br><br>
1.40 <br><br>
o ci ch3 <br><br>
pyrid-2-yl <br><br>
1.41 <br><br>
0 <br><br>
ci ch3 <br><br>
pyrid-3-yl <br><br>
1.42 <br><br>
0 <br><br>
ci ch3 <br><br>
pyrid-4-yl <br><br>
1.43 <br><br>
0 <br><br>
ci ch3 <br><br>
6-chloropyrid-3-yl <br><br>
1.44 <br><br>
o <br><br>
Br ch3 <br><br>
thien-2-yl amorphous <br><br>
1.45 <br><br>
0 <br><br>
Br ch3 <br><br>
thien-3-yl resin <br><br>
1.46 <br><br>
0 <br><br>
Br ch3 <br><br>
5-chlorothien-2-yl amorphous <br><br>
1.47 <br><br>
0 <br><br>
Br ch3 <br><br>
3-chlorothien-2-yl amorphous <br><br>
1.48 <br><br>
o <br><br>
Br ch3 <br><br>
benzo[b] thien-2-yl amorphous <br><br>
1.49 <br><br>
0 <br><br>
Br ch3 <br><br>
5-chlorobenzo[b]thien-2-yl <br><br>
1.50 <br><br>
0 <br><br>
Br ch3 <br><br>
3-chlorobenzo[b]thien-2-yl amorphous <br><br>
1.51 <br><br>
0 <br><br>
Br ch3 <br><br>
pyrid-2-yl <br><br>
1.52 <br><br>
0 <br><br>
Br ch3 <br><br>
pyrid-3-yl <br><br>
1.53 <br><br>
0 <br><br>
Br ch3 <br><br>
pyrid-4-yl <br><br>
1.54 <br><br>
0 <br><br>
Br ch3 <br><br>
6-chloropyrid-3-yl <br><br>
1.55 <br><br>
o ci ch3 <br><br>
cf3 <br><br>
1.56 <br><br>
0 <br><br>
ci ch3 <br><br>
sc2h5 <br><br>
1.57 <br><br>
o <br><br>
CI <br><br>
ch3 <br><br>
N(CH3)2 <br><br>
1.58 <br><br>
0 <br><br>
ci ch3 <br><br>
nhnh2 <br><br>
1.59 <br><br>
o ci ch3 <br><br>
N(CH3)NH2 <br><br>
1.60 <br><br>
o ci ch3 <br><br>
NHN(CH3)2 <br><br>
1.61 <br><br>
o ci c2h5 <br><br>
h oil <br><br>
o Ol -fc. W N> <br><br>
OVOOO-~JO\U»4VLOtO <br><br>
►—> <br><br>
»—I <br><br>
1—» <br><br>
H-» <br><br>
>—» <br><br>
00 <br><br>
o <br><br>
>x> <br><br>
00 <br><br>
-J <br><br>
Ov <br><br>
^-0 <br><br>
to <br><br>
^0 <br><br>
1—> <br><br>
—1 <br><br>
o <br><br>
VO 00 <br><br>
h—* <br><br>
1—» <br><br>
i—* <br><br>
►—' <br><br>
i—» <br><br>
b\ <br><br>
b\ <br><br>
ON <br><br>
b\ <br><br>
b\ <br><br>
-0 <br><br>
ON <br><br>
U> <br><br>
-P>- <br><br>
w <br><br>
0\ <br><br>
cooooooooooooooooooooooooooooooooooo QQQQQGQGQDQQQQQGQQQQQQQQQQ2QQGQQQQQG <br><br>
x ecscmffisdsqqq? ? ? zpppppppp <br><br>
5 S 5PPPP ffi s s i a i! s a <br><br>
O O O^^^^iruTuuTw^ uur so <br><br>
5s« <br><br>
as x o vo n a: <br><br>
•o <br><br>
<-c <br><br>
>1 <br><br>
fa n <br><br>
O <br><br>
N <br><br>
o n x x ro to <br><br>
C i- <br><br>
o A <br><br>
c r <br><br>
O K> <br><br>
X a o o o o o o o <br><br>
•-t-t y-ri *r* *"7** T* T* 'T4 l-L< )-W |i4 M hM N t-M <br><br>
to o o <br><br>
8 8 ft ft x n o ^ n to w ac <br><br>
Ul o o n o o o n ac ec ac ac ec •?$ ffl <br><br>
.o io to s> >o u — <br><br>
8888888888S <br><br>
0000088888% <br><br>
> Ov Ox HH 0\ V J <br><br>
r o n o a o ec ec e ac <br><br>
W >0 N> ^ >»«✓ ^ S—/ <br><br>
vo W 00 ^ <br><br>
10 o n o o aj ac as ^ <br><br>
A ft ft ^ <br><br>
HAS <br><br>
10 ^ n o <br><br>
CK ON HH 0\ <br><br>
M HH VM M <br><br>
o niJ <br><br>
" % ® <br><br>
•fl A Ui <br><br>
HH ^ <br><br>
U> <br><br>
ac <br><br>
OJ <br><br>
n o* <br><br>
ec cn w <br><br>
8 8 <br><br>
X <br><br>
u> <br><br>
o ac o. <br><br>
8 <br><br>
o n n n v; *? o ac ac B n n w <br><br>
*8 8 8^a" s b 8 <br><br>
ac i—> <br><br>
o n ac ac to OJ <br><br>
o ?! <br><br>
O <br><br>
>TJ <br><br>
*h oo n ac Q ® <br><br>
ac w o o <br><br>
LO vo <br><br>
On <br><br>
4^ ■ <br><br>
os 00 o <br><br>
>-l a> <br><br>
CO <br><br>
-j a <br><br>
V 8 <br><br>
oo 5' <br><br>
0 <br><br>
I <br><br>
cr o c <br><br>
CO <br><br>
Ui <br><br>
0 <br><br>
1 <br><br>
On O o <br><br>
Ui <br><br>
0 <br><br>
1 <br><br>
OS o o r <br><br>
c o <br><br>
£ 1 <br><br>
o o in r-cs <br><br>
»-H »—1 <br><br>
■ ■ c co <n cn 2 <br><br>
H ?H U* <br><br>
I - <br><br>
o o <br><br>
0 <br><br>
0 <br><br>
O <br><br>
CN <br><br>
cn <br><br>
0 <br><br>
0 <br><br>
m <br><br>
3 <br><br>
ON <br><br>
VO <br><br>
—* <br><br>
•M <br><br>
CN <br><br>
On 1 <br><br>
ON <br><br>
1 <br><br>
t <br><br>
1 <br><br>
, <br><br>
wo <br><br>
—-N <br><br>
C\ <br><br>
ON <br><br>
—■ <br><br>
— <br><br>
cn o <br><br>
I <br><br>
% <br><br>
n< u <br><br>
M <br><br>
X u <br><br>
CN <br><br>
X <br><br>
8 <br><br>
U <br><br>
cs Uh <br><br>
^5 <br><br>
F? § <br><br>
y. ."2 <br><br>
O <br><br>
u <br><br>
. cs y m . <s ffi. Ill tu <br><br>
V V V <br><br>
X u 5 3 <br><br>
<3 00 OS w* <br><br>
U 'Ts Is "S. ^ <br><br>
" S E S U <br><br>
o y y y y 4 ooop <br><br>
ON <br><br>
»T) <br><br>
PC ~ <br><br>
>0 HH <br><br>
35 <br><br>
V a <br><br>
•i v ffi o o 8 <br><br>
u u <br><br>
, «s , <s u* U-1 <br><br>
u u <br><br>
CS (N <br><br>
« EC 33 <br><br>
X u U <br><br>
c j cn cn <s if 33 33 33 X . . <br><br>
"8888880 <br><br>
, cs r <n U4 Uh <br><br>
V V <br><br>
32 32 U U <br><br>
m m <br><br>
33 33 <br><br>
cn cn o u cn 1 <br><br>
33 B <br><br>
\C NO <br><br>
ac x o o <br><br>
8818888888888888888888888888 <br><br>
C*lCSCN(NOJCSCS<NC*lCS(N<N CS C4 N ■ CS CN »S C> <J* . <S <S IN (N c* ot <s <br><br>
33 33 33 33 33 33 33 33 33 33 33 UUUUUUUUUUU <br><br>
33' 33" 33' 33" 33" 33 33 33 33 33 uuuuuuuuuu <br><br>
CS CS <br><br>
a x <br><br>
33 <br><br>
M cn <br><br>
V V <br><br>
X u <br><br>
<n <br><br>
® « <br><br>
I 33 <br><br>
88 <br><br>
33 <br><br>
8 8 <br><br>
8 <br><br>
8 <br><br>
8 8 <br><br>
8 <br><br>
8 8 <br><br>
«Ll f\) <br><br>
8 <br><br>
N <S <br><br>
33 33 U U <br><br>
N <br><br>
33 U <br><br>
ri r< <br><br>
33 33 U U <br><br>
ffi u m <br><br>
33 <br><br>
JF U U Z 32 <br><br>
ac u <br><br>
00 <br><br>
CN <br><br>
m <br><br>
X ? U <br><br>
z 3; <br><br>
3: u <br><br>
X <br><br>
z n o o oi c*i m <p cp to cp cp <p tp <br><br>
333333333C33 33ffipC33 3333 pC UUUUOCJUUUUUU33U33 <br><br>
d d Cp tp tp tp <br><br>
U53U33U33U33UEUS <br><br>
cn cn cn cn m o33ouun:3:iu <br><br>
UU<JUUUUUUUUUU<U< <br><br>
UtttfcfcfcfcHHtt.fcfcfcWWUUUUUUUU <br><br>
OOOOOOOOOOOOOOOOOOOOOOOOOOOO&ococo&ooo&ocooc <br><br>
O <br><br>
rH <br><br>
CN <br><br>
cn <br><br>
to vo r^ <br><br>
00 <br><br>
on <br><br>
O <br><br>
rH <br><br>
CN <br><br>
cn <br><br>
vo <br><br>
00 <br><br>
Q\ <br><br>
o o <br><br>
o <br><br>
0 <br><br>
O <br><br>
O <br><br>
0 <br><br>
0 <br><br>
0 <br><br>
O <br><br>
*—' <br><br>
*—' <br><br>
»—« <br><br>
r—f <br><br>
«-« <br><br>
f—• <br><br>
On <br><br>
ON <br><br>
rH <br><br>
r-H <br><br>
rH <br><br>
rH <br><br>
rH <br><br>
T—* <br><br>
rH <br><br>
rH <br><br>
rH <br><br>
T—( <br><br>
r-H <br><br>
rH <br><br>
1-H <br><br>
H <br><br>
T-H <br><br>
rH <br><br>
F1 H <br><br>
»■ H <br><br>
r-H* <br><br>
»■ < <br><br>
»H <br><br>
1—H <br><br>
rH <br><br>
r-H <br><br>
^H <br><br>
r-H <br><br>
T—1 <br><br>
r~H <br><br>
r—< <br><br>
»-H <br><br>
r- <br><br>
00 <br><br>
ON <br><br>
O <br><br>
r~H <br><br>
CN <br><br>
cn <br><br>
in <br><br>
NO <br><br>
r- <br><br>
00 <br><br>
ON <br><br>
O <br><br>
— CN <br><br>
<r, <br><br>
r-H <br><br>
1 ( <br><br>
■ 'i <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
CN <br><br>
cn cn cn cn rH <br><br>
rH <br><br>
rH <br><br>
rH <br><br>
rH <br><br>
rH <br><br>
i-H <br><br>
^H <br><br>
*-H <br><br>
rH <br><br>
^H <br><br>
r-H <br><br>
H <br><br>
H <br><br>
^H <br><br>
»—H <br><br>
fH <br><br>
•H <br><br>
r-J <br><br>
r-H <br><br>
— <br><br>
Bay <br><br>
-41 <br><br>
1.134 <br><br>
s ci h <br><br>
sch3 <br><br>
1.135 <br><br>
s ci ch3 <br><br>
n(och3)ch3 <br><br>
1.136 <br><br>
s ci ch3 <br><br>
och3 <br><br>
1.137 <br><br>
s ci ch3 <br><br>
oc2h5 <br><br>
1.138 <br><br>
s ci ch3 <br><br>
ch3 <br><br>
1.139 <br><br>
s ci c2h5 <br><br>
sch3 <br><br>
1.140 <br><br>
s ci c2h5 <br><br>
nhch3 <br><br>
1.141 <br><br>
s ci c2h5 <br><br>
nh2 <br><br>
1.142 <br><br>
s ci c2h5 <br><br>
n(ch3)2 <br><br>
1.143 <br><br>
s ci c2h5 <br><br>
och3 <br><br>
1.144 <br><br>
s ci n-C3H7 <br><br>
nhch3 <br><br>
1.145 <br><br>
s ci n-C3H7 <br><br>
nh2 <br><br>
1.146 <br><br>
s ci n-C3H7 <br><br>
och3 <br><br>
1.147 <br><br>
s ci coch3 <br><br>
ch3 <br><br>
1.148 <br><br>
s ci coch3 <br><br>
c2h5 <br><br>
1.149 <br><br>
s ci coch3 <br><br>
cf3 <br><br>
1.150 <br><br>
s ci coch3 <br><br>
COOCH3 <br><br>
1.151 <br><br>
s ci h <br><br>
nhch3 <br><br>
1.152 <br><br>
s <br><br>
Br h <br><br>
h <br><br>
1.153 <br><br>
s <br><br>
Br h <br><br>
ch3 <br><br>
1.154 <br><br>
s <br><br>
Br <br><br>
H <br><br>
sch3 <br><br>
1.155 <br><br>
s <br><br>
Br h <br><br>
nhch3 <br><br>
1.156 <br><br>
s <br><br>
Br h <br><br>
n(och3)ch3 <br><br>
1.157 <br><br>
s <br><br>
Br ch3 <br><br>
h <br><br>
1.158 <br><br>
s <br><br>
Br ch3 <br><br>
ch3 <br><br>
1.159 <br><br>
s <br><br>
Br ch3 <br><br>
sch3 <br><br>
1.160 <br><br>
s <br><br>
Br ch3 <br><br>
nhch3 <br><br>
1.161 <br><br>
s <br><br>
Br ch3 <br><br>
n(Och3)ch3 <br><br>
1.162 <br><br>
s <br><br>
Br coch3 <br><br>
ch3 <br><br>
1.163 <br><br>
s <br><br>
Br coch3 <br><br>
cooch3 <br><br>
1.164 <br><br>
o <br><br>
Br i-C3H7 <br><br>
ch3 <br><br>
1.165 <br><br>
o <br><br>
CI <br><br>
c2h5 <br><br>
cf3 <br><br>
1.166 <br><br>
o ci ch3 <br><br>
ch2ci <br><br>
1.167 <br><br>
o <br><br>
CI <br><br>
n-C3H7 <br><br>
H <br><br>
1.168 <br><br>
o <br><br>
CI <br><br>
n-C3H7 <br><br>
ch3 <br><br>
1.169 <br><br>
o <br><br>
CI <br><br>
ch3 <br><br>
ch2OCOC6h4NQ2(p) <br><br>
oil <br><br>
165-170° <br><br>
resin oil <br><br>
59-61° <br><br>
oil oil <br><br>
64-70° <br><br>
N) tO tO S) IO C O O O O t W IO <br><br>
O VO 00 «-J <br><br>
h~» <br><br>
H-* <br><br>
H-» <br><br>
)—k <br><br>
H-» <br><br>
h-» <br><br>
H-A <br><br>
H-* <br><br>
►—» <br><br>
►—» <br><br>
>-* <br><br>
h—1 <br><br>
>—» <br><br>
►—» <br><br>
k-* <br><br>
►—1 <br><br>
H-* <br><br>
>—» <br><br>
I-1 <br><br>
H-* <br><br>
t—* <br><br>
I—• <br><br>
VO ON <br><br>
M <br><br>
vo cn <br><br>
>—* <br><br>
vo <br><br>
►—» <br><br>
VO CO <br><br>
M <br><br>
VO N) <br><br>
►—» <br><br>
VO <br><br>
M <br><br>
VO <br><br>
o <br><br>
»—» <br><br>
00 VO <br><br>
►—» <br><br>
00 00 <br><br>
>—* <br><br>
00 -4 <br><br>
oo ON <br><br>
►—» OO <br><br>
cn <br><br>
►—* <br><br>
oo 4^ <br><br>
oo <br><br>
CO <br><br>
►—» OO <br><br>
to h-' <br><br>
OO <br><br>
M <br><br>
)—* 00 <br><br>
o vo <br><br>
H-* <br><br>
-o <br><br>
00 <br><br>
t—• <br><br>
-0 <br><br>
ON <br><br>
►—* <br><br>
cn <br><br>
•o -f* <br><br>
H-» <br><br>
-o <br><br>
CO <br><br>
V—» <br><br>
-O <br><br>
to <br><br>
<1 <br><br>
H-* <br><br>
►—* <br><br>
o cco^^^oooooooooooooooooooooooo^oooo <br><br>
QQQQQQQQQQ2?QQQQQQ2QQGQQQQQQQQQQQQQQ <br><br>
-cnoonnooooo <br><br>
V to to to <br><br>
X w <br><br>
0\ <br><br>
to to <br><br>
GGGGG89SS® <br><br>
a a a a a o a no <br><br>
O <br><br>
n o <br><br>
X <br><br>
a a <br><br>
to to to <br><br>
00 <br><br>
00 <br><br>
n o <br><br>
n o <br><br>
IT <br><br>
IT <br><br>
o <br><br>
00 <br><br>
00 <br><br>
w ac <br><br>
1 <br><br>
1 <br><br>
Q <br><br>
to <br><br>
Vi n <br><br>
O O <br><br>
u> <br><br>
O <br><br>
a <br><br>
LO <br><br>
a <br><br>
X <br><br>
ii <br><br>
-J <br><br>
n <br><br>
■n <br><br>
to to <br><br>
II II II <br><br>
WWW <br><br>
S-/ w W <br><br>
X3 3 O <br><br>
^ o X Qx> <br><br>
~ Er O K a v; <br><br>
to to n is a- <br><br>
vo a <br><br>
CC X o <br><br>
8 <br><br>
K> <br><br>
X <br><br>
o n a a to to 00 C£ <br><br>
o n <br><br>
00 00 <br><br>
is a a <br><br>
W Lrt s-/ <br><br>
O <br><br>
n a <br><br>
*®ao£888288838£88 <br><br>
^ to ^ ^LOLOtOLOCOtOtOtOLO <br><br>
Jfl -J EC EC ffi <br><br>
W LO LO LO <br><br>
r> n o o o <br><br>
EC " ' ' ~ <br><br>
EC EC EC J* <br><br>
to to <-? w w o to <br><br>
C/3 <br><br>
n <br><br>
00 <br><br>
O <br><br>
O <br><br>
u> <br><br>
EC <br><br>
-j <br><br>
O co Z O EC <br><br>
EC <br><br>
in w <br><br>
CO <br><br>
n on <br><br>
EC <br><br>
IA <br><br>
O O <br><br>
)—4 <br><br>
0 <br><br>
1 <br><br>
Jp i* <br><br>
J? a a w U> /—\ <br><br>
n o\ <br><br>
a <br><br>
LA <br><br>
8 <br><br>
O <br><br>
a w <br><br>
n o <br><br>
/-N <br><br>
o a to n <br><br>
o n <br><br>
a to <br><br>
1 <br><br>
ffi to <br><br>
1 <br><br>
a to n a to w o o o <br><br>
o <br><br>
V- <br><br>
w o o <br><br>
8 <br><br>
tP <br><br>
O <br><br>
h—• <br><br>
o o »—» <br><br>
o to to <br><br>
O <br><br>
a <br><br>
LA <br><br>
1 <br><br>
n <br><br>
1 <br><br>
o <br><br>
8 <br><br>
O <br><br>
On o o <br><br>
in a <br><br>
vo <br><br>
On a <br><br>
i—» <br><br>
*s> <br><br>
a tA <br><br>
ffi <br><br>
LA <br><br>
8 <br><br>
a to <br><br>
a to n o <br><br>
8 <br><br>
a anon a a a to to to to to to <br><br>
1 <br><br>
o n re ac <br><br>
*o <br><br>
8a si g -3 <br><br>
to cr o <br><br>
■«w <br><br>
LA H-« <br><br>
O ,» <br><br>
a ~ <br><br>
h a <br><br>
to o o a a to to <br><br>
8 8 <br><br>
88 <br><br>
ON ON <br><br>
PB <br><br>
8 8 <br><br>
W *o <br><br>
M-l w w <br><br>
/■—s <br><br>
•a <br><br>
-p* to r. o v. w <br><br>
P <br><br>
C5 <br><br>
P <br><br>
3 <br><br>
3 <br><br>
3 <br><br>
o o <br><br>
o <br><br>
—i <br><br>
T3 <br><br>
-n T3 <br><br>
•3 <br><br>
3* <br><br>
nr <br><br>
3* <br><br>
O <br><br>
o o <br><br>
c c <br><br>
C <br><br>
05 <br><br>
C/3 <br><br>
00 <br><br>
o ON <br><br>
O o <br><br>
O O O O <br><br>
00 Ul c3 <br><br>
GO <br><br>
a a e e <br><br>
, w S8 S § § <br><br>
vo 5' »' 5' ^ <br><br>
tr tr <br><br>
O O <br><br>
c: a <br><br>
CO C/5 <br><br>
co CO <br><br>
I—* <br><br>
CO <br><br>
cn o <br><br>
H H <br><br>
CD CO <br><br>
00 CO <br><br>
h-»« M( <br><br>
a s <br><br>
resin <br><br>
3 <br><br>
00 <br><br>
3 <br><br>
§ <br><br>
5- <br><br>
5' <br><br>
s* <br><br>
5' <br><br>
3 <br><br>
03 <br><br>
I <br><br>
I—* <br><br>
w <J\ <br><br>
3 52. <br><br>
M <br><br>
g. <br><br>
s <br><br>
3 <br><br>
3 <br><br>
CO -J o <br><br>
00 <br><br>
I <br><br>
t—» <br><br>
to U\ o <br><br>
CD CD CO CO <br><br>
Cn SO <br><br>
i <br><br>
ON CO o <br><br>
CD <br><br>
C/i <br><br>
CD <br><br>
ro <br><br>
C^3 <br><br>
-43- <br><br>
27j2-3 <br><br>
Table 2 <br><br>
Rf^X <br><br>
comp. no. X Rj R2 R3 R17 physic, data <br><br>
2.01 <br><br>
0 <br><br>
ci ch3 <br><br>
h <br><br>
3-Br oil <br><br>
2.02 <br><br>
0 <br><br>
ci ch3 <br><br>
ch3 <br><br>
3-Br <br><br>
97-99° <br><br>
2.03 <br><br>
0 <br><br>
ci ch3 <br><br>
C-C3H5 <br><br>
3-Br oil <br><br>
2.04 <br><br>
0 <br><br>
ci ch3 <br><br>
cf3 <br><br>
3-Br <br><br>
107-109° <br><br>
2.05 <br><br>
0 <br><br>
ci c2h5 <br><br>
h <br><br>
3-Br <br><br>
65-68° <br><br>
2.06 <br><br>
0 <br><br>
ci c2h5 <br><br>
cf3 <br><br>
3-Br oil <br><br>
2.07 <br><br>
0 <br><br>
ci c2h5 <br><br>
ch3 <br><br>
3-Br oil <br><br>
2.08a1 <br><br>
0 <br><br>
ci ch3 <br><br>
c6h4c1(4) <br><br>
3-c1 <br><br>
83-85° <br><br>
2.09b1 <br><br>
0 <br><br>
ci ch3 <br><br>
c6h4c1(4) <br><br>
3-c1 <br><br>
130-133° <br><br>
2.10 <br><br>
0 <br><br>
ci ch3 <br><br>
cf3 <br><br>
3-c1 <br><br>
96-98° <br><br>
2.11 <br><br>
0 <br><br>
ci i-C3H7 <br><br>
ch3 <br><br>
3-Br oil <br><br>
2.12 <br><br>
0 <br><br>
ci ch3 <br><br>
H <br><br>
3-c1 <br><br>
resin <br><br>
1 A and B denote isomers <br><br>
-44- <br><br>
270 <br><br>
Table 3 <br><br>
R3"^X <br><br>
comp. no. <br><br>
X <br><br>
R1 <br><br>
r2 <br><br>
R3 <br><br>
R17 <br><br>
physic, data <br><br>
3.01 <br><br>
O <br><br>
ci ch3 <br><br>
H <br><br>
H <br><br>
116-117° <br><br>
3.02 <br><br>
o ci ch3 <br><br>
ch3 <br><br>
H <br><br>
resin <br><br>
3.03 <br><br>
0 <br><br>
F <br><br>
ch3 <br><br>
N(OCH3)CH3 <br><br>
H <br><br>
resin <br><br>
3.04 <br><br>
o <br><br>
Br ch3 <br><br>
ch3 <br><br>
H <br><br>
wax <br><br>
3.05A1 <br><br>
o <br><br>
Br ch3 <br><br>
i-C3H7 <br><br>
h wax <br><br>
3.05B1 <br><br>
o <br><br>
Br ch3 <br><br>
i-C3H7 <br><br>
H <br><br>
wax <br><br>
3.06 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
H <br><br>
H <br><br>
129-130° <br><br>
3.07 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
CH3 <br><br>
H <br><br>
resin <br><br>
3.08 <br><br>
o ci ch3 <br><br>
ch3 <br><br>
3-C1 <br><br>
resin <br><br>
3.09 <br><br>
o ci ch3 <br><br>
H <br><br>
3-C1 <br><br>
118-120° <br><br>
3.10 <br><br>
o <br><br>
F <br><br>
ch3 <br><br>
H <br><br>
3-C1 <br><br>
129-131° <br><br>
3.11A1 <br><br>
o ci ch3 <br><br>
(CH3)3CH=CF2 <br><br>
3-CH2CH=CH2 <br><br>
resin <br><br>
3.11B1 <br><br>
o ci ch3 <br><br>
(CH3)3CH=CF2 <br><br>
3-CH2CH=CH2 <br><br>
resin <br><br>
3.12 <br><br>
o ci ch3 <br><br>
ch3 <br><br>
3-CH2CH=CH2 <br><br>
glass-like <br><br>
3.13 <br><br>
o ci ch3 <br><br>
CH2-t-C4H9 <br><br>
3-CH2CH=CH2 <br><br>
resin <br><br>
3.14 <br><br>
o <br><br>
Br ch3 <br><br>
n"C3H7 <br><br>
H <br><br>
101-107° <br><br>
3.15 <br><br>
o <br><br>
Br ch3 <br><br>
c-C3H5 <br><br>
H <br><br>
83-91° <br><br>
3.16 <br><br>
o <br><br>
Br ch3 <br><br>
c2h5 <br><br>
H <br><br>
resin <br><br>
3.17 <br><br>
o <br><br>
Br ch3 <br><br>
ch2ci <br><br>
H <br><br>
resin ~ <br><br>
3.18 <br><br>
o <br><br>
Br ch3 <br><br>
i-C4H9 <br><br>
h <br><br>
97-103° <br><br>
1 A and B denote isomers <br><br>
-45- <br><br>
C/W23S <br><br>
Table 4 <br><br>
comp. no. <br><br>
Z <br><br>
R1 <br><br>
R19 <br><br>
r2 <br><br>
R19 <br><br>
4.01 <br><br>
s ci ch3 <br><br>
4-ch3 <br><br>
4.02 <br><br>
s ci ch3 <br><br>
5-ch3 <br><br>
4.03 <br><br>
s ci ch3 <br><br>
4-c1 <br><br>
4.04 <br><br>
s ci ch, <br><br>
5-c1 <br><br>
4.05 <br><br>
s ci ch3 <br><br>
4-cf3 <br><br>
4.06 <br><br>
s ci ch3 <br><br>
5-cf3 <br><br>
4.07 <br><br>
s ci h <br><br>
4-c1 <br><br>
4.08 <br><br>
s ci h <br><br>
5-c1 <br><br>
4.09 <br><br>
s ci h <br><br>
4-cf3 <br><br>
4.10 <br><br>
s ci h <br><br>
5-cf3 <br><br>
4.11 <br><br>
0 <br><br>
ci ch3 <br><br>
4-ch3 <br><br>
4.12 <br><br>
0 <br><br>
ci ch3 <br><br>
5-CH3 <br><br>
4.13 <br><br>
0 <br><br>
ci ch3 <br><br>
4-c1 <br><br>
4.14 <br><br>
0 <br><br>
ci ch3 <br><br>
5-c1 <br><br>
4.15 <br><br>
0 <br><br>
ci ch3 <br><br>
4-cf3 <br><br>
4.16 <br><br>
0 <br><br>
ci ch3 <br><br>
5-cf3 <br><br>
4.17 <br><br>
0 <br><br>
ci h <br><br>
4-cf3 <br><br>
4.18 <br><br>
0 <br><br>
ci h <br><br>
5-cf3 <br><br>
4.19 <br><br>
s <br><br>
Br ch3 <br><br>
4-ch3 <br><br>
4.20 <br><br>
s <br><br>
Br ch3 <br><br>
5-ch3 <br><br>
4.21 <br><br>
s <br><br>
Br ch3 <br><br>
4-cl <br><br>
4.22 <br><br>
s <br><br>
Br ch, <br><br>
5-cl <br><br>
4.23 <br><br>
s <br><br>
Br ch, <br><br>
4-CF3 <br><br>
physic, data resin <br><br>
-46- <br><br>
4.24 <br><br>
s <br><br>
Br ch3 <br><br>
5-cf3 <br><br>
4.25 <br><br>
s <br><br>
Br h <br><br>
4-c1 <br><br>
4.26 <br><br>
s <br><br>
Br h <br><br>
5-c1 <br><br>
4.27 <br><br>
s <br><br>
Br h <br><br>
4-cf3 <br><br>
4.28 <br><br>
s <br><br>
Br h <br><br>
5-cf3 <br><br>
4.29 <br><br>
0 <br><br>
Br ch3 <br><br>
4-ch3 <br><br>
4.30 <br><br>
0 <br><br>
Br ch3 <br><br>
5-ch3 <br><br>
4.31 <br><br>
0 <br><br>
Br ch3 <br><br>
4-c1 <br><br>
4.32 <br><br>
0 <br><br>
Br ch3 <br><br>
5-c1 <br><br>
4.33 <br><br>
0 <br><br>
Br ch3 <br><br>
4-cf3 <br><br>
4.34 <br><br>
0 <br><br>
Br ch3 <br><br>
5-cf3 <br><br>
4.35 <br><br>
0 <br><br>
Br h <br><br>
4-cf3 <br><br>
4.36 <br><br>
0 <br><br>
Br h <br><br>
5-cf3 <br><br>
4.37 <br><br>
s f <br><br>
ch3 <br><br>
4-ch3 <br><br>
4.38 <br><br>
s f <br><br>
ch3 <br><br>
5-ch3 <br><br>
4.39 <br><br>
s f <br><br>
ch3 <br><br>
4-c1 <br><br>
4.40 <br><br>
s f <br><br>
ch3 <br><br>
5-c1 <br><br>
4.41 <br><br>
s f <br><br>
ch3 <br><br>
4-cf3 <br><br>
4.42 <br><br>
s f <br><br>
ch3 <br><br>
5-cf3 <br><br>
4.43 <br><br>
s f <br><br>
h <br><br>
4-c1 <br><br>
4.44 <br><br>
s f <br><br>
h <br><br>
5-c1 <br><br>
4.45 <br><br>
s f <br><br>
h <br><br>
4-cf3 <br><br>
4.46 <br><br>
s f <br><br>
h <br><br>
5-cf3 <br><br>
4.47 <br><br>
0 <br><br>
f ch3 <br><br>
4-ch3 <br><br>
4.48 <br><br>
0 <br><br>
f ch3 <br><br>
5-ch3 <br><br>
4.49 <br><br>
0 <br><br>
f ch3 <br><br>
4-c1 <br><br>
4.50 <br><br>
0 <br><br>
f ch3 <br><br>
5-c1 <br><br>
4.51 <br><br>
0 <br><br>
f ch3 <br><br>
4-CF3 <br><br>
4.52 <br><br>
0 <br><br>
f ch3 <br><br>
5-CF3 <br><br>
4.53 <br><br>
0 <br><br>
f h <br><br>
4-CF3 <br><br>
4.54 <br><br>
0 <br><br>
f h <br><br>
5-cf3 <br><br>
a) <br><br>
b) <br><br>
c) <br><br>
25% <br><br>
40% <br><br>
50% <br><br>
5% <br><br>
8% <br><br>
6% <br><br>
-47- <br><br>
Formulation Examples (throughout, percentages ars by weight) <br><br>
Example Fl: Emulsifiable concentrates active ingredient calcium dodecylbenzenesulfonate castor oil polyethylene glycol ether <br><br>
(36 mol of ethylene oxide) 5% - <br><br>
tributylphenol polyethylene glycol ether <br><br>
(30 mol of ethylene oxide) - 12% 4% <br><br>
cyclohexanone - 15% 20% <br><br>
xylene mixture 65% 25% 20% <br><br>
The finely ground active ingredient is mixed with the adjuvants, giving an emulsifiable concentrate from which emulsions of any desired concentration can be prepared by dilution with water. <br><br>
Example F2: Solutions a) b) c) d) <br><br>
active ingredient 80% 10% 5% 95% <br><br>
ethylene glycol monomethyl ether 20% - <br><br>
polyethylene glycol <br><br>
(mol. wt. 400) - 70% - <br><br>
N-methylpyrrolid-2-one - 20% - <br><br>
epoxidised coconut oil - - 1% 5% <br><br>
petroleum fraction <br><br>
(boiling range: 160-190°) - - 94%- <br><br>
The finely ground active ingredient is mixed with the adjuvants, giving a solution that is suitable for application in the form of microdrops. <br><br>
Example F3: Granules a) b) c) d) <br><br>
active ingredient 5% 10% 8% 21% <br><br>
kaolin 94% - 79% 54% <br><br>
highly dispersed silicic acid 1% - 13% 7% <br><br>
attapulgite - 90% - 18% <br><br>
The active ingredient is dissolved in dichloromethane, the solution is sprayed onto the <br><br>
-48- <br><br>
carrier mixture, and the solvent is evaporated off in vacuo. <br><br>
Example F4: Dusts active ingredient highly dispersed silicic acid 1% <br><br>
talcum kaolin a) b) 2% 5% <br><br>
5% <br><br>
97% <br><br>
90% <br><br>
Ready-for-use dusts are obtained by mixing the active ingredient with the earners. <br><br>
The active ingredient is mixed with the adjuvants and the mixture is ground in a suitable mill, affording wettable powders which can be diluted with water to give suspensions of any desired concentration. <br><br>
Example F6: Emulsifiable concentrate active ingredient 10% <br><br>
octylphenol polyethylene glycol ether <br><br>
(4-5 mol of ethylene oxide) 3% <br><br>
calcium dodecylbenzenesulfonate 3% <br><br>
castor oil polyethylene glycol ether <br><br>
(36 mol of ethylene oxide) 4% <br><br>
cyclohexanone 30% <br><br>
xylene mixture 50% <br><br>
Example F5: Wettable powders active ingredient sodium lignosulfonate sodium lauryl sulfate sodium diisobutylnaphthalenesulfonate octylphenol polyethylene glycol ether <br><br>
(7-8 mol of ethylene oxide) <br><br>
highly dispersed silicic acid kaolin a) b) c) 25% 50% 75% 5% 5% - <br><br>
2% -5% 10% 10% 62% 27% - <br><br>
3% - 5% 6% 10% <br><br>
The finely ground active ingredient is mixed with the adjuvants, giving an emulsifiable concentrate from which emulsions of any desired concentration can be prepared by <br><br>
-49- <br><br>
dilution with water. <br><br>
Example F7: Dusts a) b) <br><br>
active ingredient 5% 8% <br><br>
talcum 95% - <br><br>
kaolin - 92% <br><br>
Ready-for-use dusts are obtained by mixing the active ingredient with the carriers and grinding the mixture in a suitable mill. <br><br>
Example F8: Extruder granules active ingredient 10% <br><br>
sodium lignosulfonate 2% <br><br>
carboxymethylcellulose 1% <br><br>
kaolin 87% <br><br>
The active ingredient is mixed with the adjuvants, and the mixture is ground, moistened with water, extruded and granulated, and the granules are then dried in a stream of air. <br><br>
Example F9: Coated granules active ingredient 3% <br><br>
polyethylene glycol (mol. wt 200) 3% <br><br>
kaolin 94% <br><br>
The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol, affording non-dusty coated granules. <br><br>
Example F10: Suspension concentrate active ingredient 40% <br><br>
ethylene glycol 10% <br><br>
nonylphenol polyethylene glycol ether <br><br>
(15 mol of ethylene oxide) 6% <br><br>
sodium lignosulfonate 10% carboxymethylcellulose 1% <br><br>
aqueous formaldehyde solution (37%) 0.2% <br><br>
aqueous silicone oil emulsion (75%) 0.8% <br><br>
-50- <br><br>
270235 <br><br>
water 32% <br><br>
The finely ground active ingredient is mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired concentration can be obtained by dilution with water. <br><br>
Biological Examples <br><br>
Exar- 'e Bl: Action against Diabrotica balteata <br><br>
Maize seedlings are sprayed with an aqueous emulsion comprising 400 ppm of test compound. After the spray coating has dried, the maize seedlings are populated with 10 Diabrotica balteata larvae in the second stage and then placed in a plastics container. <br><br>
6 days later, the percentage reduction in the population (% activity) is determined by comparing the number of dead larvae on the treated plants with that on untreated plants. <br><br>
Compounds of Tables 1 to 4 exhibit good activity in this test. In particular, compounds 1.3,1.5, 1.7 to 1.11, 1.13,1.15,1.17,1.19, 1.21 to 1.23,1.77 to 1.79, 1.134,1.151,1.174 to 1.177, 1.179, 1.183 to 1.189,1.191, 1.193 to 1.196, 1.198, 2.01, 2.04 to 2.07, 2.11,2.12, 3.01 to 3.08, 3.10,3.15,3.16 and 4.01 are more than 80 % effective. <br><br>
Example B2: Action against Heliothis virescens <br><br>
Young soybean plants are sprayed with an aqueous emulsion comprising 400 ppm of test compound. After the spray coating has dried, the soybean plants are populated with 10 . Heliothis virescens caterpillars in the first stage and then placed in a plastics container. 6 days later, the percentage reduction in the population and the percentage reduction in feeding damage (% activity) is determined by comparing the number of dead caterpillars and the feeding damage on the treated plants with that on untreated plants. <br><br>
Compounds of Tables 1 to 4 exhibit good activity in this test. In particular, compounds 1.1 to 1.3,1.5 to 1.22,1.77 to 1.80,1.126 to 1.129,1.132 to 1.134,1.151,1.176 to 1.178, 1.183, 1.195, 1.196, 1.198, 2.11,3.01,3.02, 3.04 to 3.07, 3.15, 3.16 and 4.01 are more than 80 % effective. <br><br>
Example B3: Action against Heliothis virescens (ovicida!) <br><br>
Egg deposits of Heliothis virescens on filter paper are immersed for a short time in an aqueous acetone solution comprising 400 ppm of test compound. After the test solution <br><br>
-51 - <br><br>
270235 <br><br>
has dried, the eggs are incubated in petri dishes. After 6 days, the percentage of eggs that have hatched is evaluated in comparison with untreated controls {% reduction in the hatching rate). <br><br>
Compounds of Tables 1 to 4 exhibit good activity in this test In particular, compounds 1.1 to 1.3,1.5 to 1.11,1.13 to 1.22,1.77 to 1.80,1.126 to 1.129,1.132 to 1.134, 1.151, 1.176 to 1.178,1.183, 1.195 to 1.198,2.01,2.04 to 2.06,2.09,2.11,2.12,3.01,3.02,3.04, 3.06, 3.07,3.15, 3.16 and 4.01 are more than 80 % effective. <br><br>
Example B4: Action against Plutella xvlostella <br><br>
Young cabbage plants are sprayed with an aqueous emulsion comprising 400 ppm of test compound. After the spray coating has dried, the cabbage plants are populated with 10 Plutella xylostella caterpillars in the third stage and then placed in a plastics container. 3 days later, the percentage reduction in the population and the percentage reduction in feeding damage (% activity) is determined by comparing the number of dead caterpillars and the feeding damage on the treated plants with that on untreated plants. <br><br>
Compounds of Tables 1 to 4 exhibit good activity in this test. In particular, compounds 1.1 to 1.3,1.5 to 1.11, 1.13 to 1.22, 1.77 to 1.80,1.126 to 1.129,1.132 to 1.134, 1.175 to 1.178,1.183, 1.195,1.196,1.198,2.11, 3.01,3.02,3.04 to 3.06, 3.14 to 3.16 and 4.01 are more than 80 % effective. <br><br>
Example B5: Action against Spodoptera littoralis <br><br>
Young soybean plants are sprayed with an aqueous emulsion comprising 400 ppm of test compound. After the spray coating has dried, the soybean plants are populated with 10 Spodoptera littoralis caterpillars in the third stage and then placed in a plastics container. 3 days later, the percentage reduction in the population and the percentage reduction in feeding damage (% activity) is determined by comparing the number of dead caterpillars and the feeding damage on the treated plants with that on untreated plants. <br><br>
Compounds of Tables 1 to 4 exhibit good activity in this test. In particular, compounds 1.1 to 1.22, 1.77 to 1.80, 1.126 to 1.129,1.132,1.134, 1.175 to 1.178, 1.183, 1.195 to 1.198, 2.11, 3.01, 3.02, 3.04 to 3.07,3.14 to 3.16 and 4.01 are more than 80 % effective. <br><br>
Example B6: Action against Boophilus microplus <br><br>
Adult female ticks which have sucked themselves full are attached to a PVC board and <br><br></p>
</div>
Claims (14)
1. A compound of formula<br><br>
(Ri<br><br>
(D,<br><br>
wherein m is 0,1,2,3 or 4, and, when m is greater than 1, the radicals R17 are identical or different;<br><br>
n is 0,1,2,3,4 or 5, and, when n is greater than 1, the radicals Rj are identical or different;<br><br>
Rx and R17 are each independently of the other,/ halogen, C^-Cgalkyl, halo-C-j-Cgalkyl, phenoxy, phenylthio, halo-Cj-Cgalkylthio, phenyl, C1-C8alkylthio, Cj-Cgalkyl-carbonyl, 0S02R4, S02NR13R14 or P^Y^^R^;<br><br>
either X is S, R2 is R21 or H and R3 is R31, -NR5R<5 or -OR2,<br><br>
or X is O, R2 is R21 and R3 is R31,<br><br>
or X is O, R2 is H and R3 is -RgOR§, -RgOCORj( -RjNRjqRjj or -RgRj2,<br><br>
or X and R3 together are Rlg;<br><br>
Y is O or S;<br><br>
R4 is CrC8alkyl, halo-C1-C8alkyl or halo-C1-Cgalkoxy;<br><br>
R21 is CrC8alkyl, C3-C6cycloalkyl, halo-C1-C8alkyl, C1-C4alkoxy-C1-C4alkyl, C1-C4-alkylthio-C1-C4alkyl, R13R14N-C1-C4alkyl, C2-C8alkenyl, C2-C8alkynyl, CrC4acyl, CH=C(CN)2. or phenyl which is unsubstituted or substituted by from one to five substituents selected from the group consisting of halogen, C1-C4alkyl, C2-C5-alkenyl, halo-C1-C4alkyl, CrC4alkoxy, S02NR13R14, halo-CrC4alkoxy, CrC4-alkylthio, CrC4alkoxy-CrC4a]koxy, halo-CrC4alkylthio, NR13R14, -N02 and -CN; R31 is H, Cj-Cgalkyl, C3-C6cycloalkyl, C3-C6cycloalkyl-C1-C3alkyl, halo-C,-C8alkyl, halo-C3-C6cycloalkyl-C1-C3alkyl, C2-C8alkenyl, C2-C8alkynyl, halo-C2-C8alkenyl, -COOR7, -SR2, -R8ORC), -RgOCORg, -R8NRJQRjj, -R8RJ2, -RgSRj, -R8SCSRg,<br><br>
phenyl which is unsubstituted or substituted by from one to five substituents selected from the group consisting of halogen, CrC4alkyl, C2-C5alkenyl, halo-CrC4alkyl, halo-Cj-C4alkoxy, halo-CrC4alkylthio, S02NR13R]4, C,-C4alkoxy, -N02 and -CN;<br><br>
270235<br><br>
-54-<br><br>
or an unsubstituted or substituted, saturated or unsaturated,<br><br>
five- or six- mattered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group consisting of halogen, C1-C4alkyl, halo-Cj-Qalkyl and CrC4alkoxy;<br><br>
R5 and R6 are each independently of the other H, CrC8alkyl, halo-CrCgalkyl, C2-C5-alkenyl, CrC4alkoxy, C2-C5alkenyloxy or -NR13R14;<br><br>
R7 is H, CrC8alkyl, halo-CrC8alkyl or C2-C8alkenyl;<br><br>
R8 is (CR15R16)p, wherein p is 1,2,3 or 4;<br><br>
Rg is CrC8alkyl, halo-C1-C11alkyl, C3-C6cycloalkyl, C2-C8alkenyl, halo-C2-Cnalkenyl, C2-C8alkynyl, NR10Rn, OR10, benzyl, or phenyl which is unsubstituted or substituted by from one to five substituents selected from the group consisting of halogen, CrC4alkyl, C2-C5alkenyl, halo-CrC4alkyl, C1-C4alkoxy, -N02 and -CN;<br><br>
R10 and Rn are each independently of the other C^Cgalkyl, Cj-Cgalkenyl or C i -Csalkoxy-Cj -C8alkyl;<br><br>
Ri:, is an unsubstituted or substituted, saturated or unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing from one to three hetero atoms selected from the group O, N and S, the substituents being selected from the group consisting of halogen, C1-C4alkyl, halo-C1-C4alkyl and CrC4alkoxy;<br><br>
R13 and R14 are each independently of the other H or Cj-Cgalkyl;<br><br>
R15 and R16 are each independently of the other H, CrC8alkyl, or phenyl which is unsubstituted or substituted by from one to five substituents selected from the group consisting of halogen, CrC4alkyl, C2-C5alkenyl, halo-CrC4alkyl, CrC4alkoxy, -N02 and -CN;<br><br>
R18 is NC(R19)=C(R19)S, NC(R19)=C(R19)0„ NC(R19)2C(R19)2S, NC(R19)2C(R19)20, NC(R19)=C(R19)C(R19)=N or NC(R19)=NC(R19)=N;<br><br>
R19 is H, Q-Qalkyl, halogen or halo-Cj-Qalkyl;<br><br>
R22 is CrC4alkyl, C1-C4alkoxy or NR13R14; and<br><br>
R23 is CrC4alkyl, CrC4alkoxy, C3-C4alkylthio or NR13R14,<br><br>
with the proviso that, in the compounds of formula I, R2 is other than H when either m is<br><br>
0, n is 1, Rj is 4-C1, R3 is -N(OCH3)CH3> R4 is CF3 and X is s, or when m is 0, n is 2, Rj is 3,4-dichloro, R3 is -N(OCH3)CH3, R4 is CF3 and X is S, or when m is 0, n is 1, Rj is<br><br>
4-C1, R3 is -NHNH2, R4 is CF3 and X is S, or, as the case may be, a tautomer thereof, in each case in free form or in salt Ibrm. ,-t<br><br>
2. A compound according to claim 1 of formula 1, wherein \<br><br>
2/023<br><br>
-55 -<br><br>
m is 0 or 1,<br><br>
or, as the case may be, a tautomer thereof.<br><br>
3. A compound according to claim 1 of formula I, wherein m is 0;<br><br>
n is 1;<br><br>
Rj is fluorine, chlorine or bromine;<br><br>
R2 is C1-C4alkyl, formyl or acetyl;<br><br>
R3 is H, CrC4alkyl, C3-C6cycloalkyl, halo-CrC2alkyl, halocyclopropylmethyl, C2-C4-alkenyl, -COOR7, -SR2, -R8-OCOR9, -Rg-Ri2 or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing N or S, the substituents being selected from the group fluorine and chlorine; R4 is trifluoromethyl;<br><br>
R7 is methyl or ethyl;<br><br>
Rg is CR15R16;<br><br>
Rg is C1-C4alkyl, halo-C8-Cnalkyl, cyclopropyl, vinyl, halo-C8-Cnalkenyl, ethynyl or unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of chlorine, methyl, methoxy and -N02;<br><br>
R12 is an unsubstituted, unsaturated, five-membered heterocyclic ring containing from one to three hetero atoms selected from the group N and S; and R15 and R16 are each independently of the other H, methyl or phenyl,<br><br>
or, as the case may be, a tautomer thereof.<br><br>
4. A compound according to claim 1 of formula I, wherein m is 0;<br><br>
n is 1;<br><br>
Rj is fluorine, chlorine or bromine;<br><br>
R2 is CrC4alkyl, formyl or acetyl;<br><br>
R3 is H, CrC4alkyl, C3-C6cycloalkyl, halo-Cj-Qalkyl, halocyclopropylmethyl, C2-C4-alkenyl, -COOR7, -SR2, -Rg-OCORg, -R8-R12 or an unsubstituted or substituted, unsaturated, five- or six-membered heterocyclic or heterobicyclic ring containing N or S, the substituents being selected from the group fluorine and chlorine; R4 is trifluoromethyl;<br><br>
R7 is methyl or ethyl;<br><br>
Rg is CH2, C(methyl)2 or CH(phcnyl);<br><br>
Ry is CrC4a!kyl, halo-CK-C, ,tilkyl, cyclopropyl, vinyl, halo-C8-C, ,alkcnyl, ethynyl or<br><br>
270235<br><br>
-56-<br><br>
unsubstituted or mono-substituted phenyl, the substituents being selected from the group consisting of chlorine, methyl, methoxy and -N02; and R12 is an unsubstituted, unsaturated, five-membered heterocyclic ring containing from one to three hetero atoms selected from the group N and S,<br><br>
or, as the case may be, a tautomer thereof.<br><br>
5.4-Chloro-4'-trifluoromethanesulfonyloxybenzophenone-N-formyl-N-methylhydrazone according to claim 1.<br><br>
6. A process for the preparation of a compound according to claim 1 of formula I or, as the case may be, a tautomer thereof, in each case in free form or in salt form, taking into account the proviso mentioned above, in which process a) a compound of formula which is known or can be prepared analogously to corresponding known compounds and wherein m, n, Rj, R2, R4 and R17 are as defined in claim 1 for formula I, or, as the case may be, a tautomer thereof, in free form or in salt form, is reacted with phosgene or tliiophosgene and the intermediate, which is optionally isolated, is reacted with a compound of formula Y]H, wherein Yj is -NR5R5, -OR2 or -SR2 and R2, R5 and Rg are as defined in claim 1 for formula I, or with a salt thereof, or b) for the preparation of a compound of formula I wherein X is O, a compound of formula II is reacted, if desired in the presence of a base, with a compound of formula R3COY2, wherein R3 is as defined in claim 1 for formula I with the exception of the meanings -OR2 and -SR2, wherein R2 is as defined in claim 1 for formula I, and Y2 is a leaving group, or c) for the preparation of a compound of formula I wherein X is S, a compound of formula II is reacted with a compound of formula Y3-N=C=S, wherein Y3 is H, Cj-Cgalkyl, halo-Cj-C8alkyl or C2-C5alkenyl, preferably H ounds of<br><br>
"NH<br><br>
1<br><br>
-57-<br><br>
270235<br><br>
formula I wherein X is S, or d) for the preparation of a compound of formula I wherein X is S and R3 is -SR, wherein R is Ci-Cgalkyl, Cj-Cgcycloalkyl, C2-Cgalkenyl or C2-Cgalkynyl, a compound of formula II is reacted with CS2, and the intermediate, which is optionally isolated, is reacted with a compound of formula RY4, wherein R is as defined above and Y4 is a leaving group, or e) for the preparation of a compound of formula I wherein X is 0, a compound of formula II is reacted with a compound of formula CIRgCOYs, wherein Rg is as defined in claim 1 for formula I and Y5 is a leaving group, and the resulting intermediate is reacted with a compound of formula R9COOH, HNR^oRll or R12> wherein R9, Rjq, Ril and R12 are as defined in claim 1 for formula I, or f) for the preparation of a compound of formula I wherein X is S, a compound of formula which is known or can be prepared analogously to corresponding known compounds, for example in accordance with Variant b), and wherein m, n, Rlf R2, R3, R4 and R17 are as defined in claim 1 for formula I, is reacted with P2S5, or g) for the preparation of a compound of formula I wherein X is S and R2 is H, a compound of formula<br><br>
OH),<br><br>
(IV),<br><br>
yT\Ct<br><br>
-58-<br><br>
270235.<br><br>
which is known or can be prepared analogously to corresponding known compounds and wherein m, n, Rlt R3, R4 and R17 are as defined in claim 1 for formula I, is reacted with H2S, or h) a compound of formula I wherein R2 is H is reacted with a ccnpound of formula I^Yg, wherein R2 is as defined in claim 1 for formula I with the exception of the meaning H, and Yg is a leaving group, or i) a compound of formula which is known or can be prepared analogously to corresponding known compounds and wherein m, n, Rl5 R4 and R17 are as defined for formula I, is reacted with a coitpound of formula which is known or can be prepared analogously to corresponding known compounds and wherein R2, R3 and X are as defined in claim 1 for formula I, or with a salt thereof and/or, as the case may be, with a tautomer thereof,<br><br>
and in each case, if desired, a compound of formula I obtainable according to the process or by other means, or a tautomer thereof, in each case in free form or in salt form, is converted into a different compound of formula I or a tautomer thereof, a mixture of isomers obtainable according to the process is separated and the desired isomer is isolated and/or a free compound of formula I obtainable according to the process, or a tautomer thereof, is converted into a salt, or a salt of a compound of formula I or of a tautomer thereof obtainable according to the process is converted into the free compound of formula I or a tautomer thereof or into a different salt.<br><br>
7. A pesticidal composition which comprises at least one compound according to claim 1 of formula I or, as the case may be, a tautomer thereof, in each case in free form or in the form of an agrochemically acceptable salt, as active ingredient and, where appropriate, ai least one adjuvant.<br><br>
O<br><br>
(V),<br><br>
(VI),<br><br>
270235<br><br>
-59-<br><br>
8. A process for the preparation of a composition according to claim 7 comprising at least one adjuvant, which process comprises homogeneously mixing and/or grinding the active ingredient with the adjuvant(s).<br><br>
9. The use of a compound according to claim 1 of formula I or, as the case may be, a tautomer thereof, in each case in free form or in the form of an agrochemically acceptable salt, in the preparation of a composition according to claim 7.<br><br>
10. The use of a composition according to claim 7 in the control of pests.<br><br>
11. The use according to claim 10 in the protection of plant propagation material.<br><br>
12. A method of controlling pests, which comprises applying to the pests or their habitat a composition according to claim 7, with the proviso that the treatment of humans is excluded.<br><br>
13. A method according to claim 12 for the protection of plant propagation material,<br><br>
which comprises treating the propagation material or the planting site of the propagation material.<br><br>
14. Plant propagation material treated in accordance with the method described in claim 13.<br><br>
CIBA-GEIGY AG<br><br>
BY THEIR ATTORNEYS BALDWIN, SON & CAREY<br><br>
</p>
</div>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1194 | 1994-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ270235A true NZ270235A (en) | 1996-11-26 |
Family
ID=4177388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ270235A NZ270235A (en) | 1994-01-05 | 1994-12-21 | Substituted sulphonyloxy benzophenone hydrazone derivatives; pesticides |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0662472B1 (en) |
JP (1) | JPH07242618A (en) |
KR (1) | KR950032106A (en) |
CN (1) | CN1108646A (en) |
AT (1) | ATE163922T1 (en) |
AU (1) | AU1004195A (en) |
CA (1) | CA2139465A1 (en) |
DE (1) | DE59405428D1 (en) |
ES (1) | ES2115190T3 (en) |
NZ (1) | NZ270235A (en) |
SG (1) | SG43002A1 (en) |
ZA (1) | ZA9528B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN186549B (en) * | 1995-04-19 | 2001-09-29 | Kumiai Chemical Co Ltd | |
AU2452997A (en) * | 1996-05-09 | 1997-11-26 | E.I. Du Pont De Nemours And Company | Benzophenone hydrazone arthropodicides |
CN1259118A (en) * | 1997-06-03 | 2000-07-05 | 诺瓦提斯公司 | organic compounds |
CN102924355A (en) * | 2012-11-09 | 2013-02-13 | 商丘师范学院 | 2-substituted benzaldehyde s-benzyldithiocarbazate Schiff base zinc and nickel coordination compound and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ189705A (en) * | 1978-03-01 | 1981-07-13 | Boots Co Ltd | Benzophenone-hydrazone derivatives and pesticidal compositions intermediates |
ATE12100T1 (en) * | 1979-08-31 | 1985-03-15 | Fbc Ltd | SUBSTITUTED BENZOPHENONE HYDRAZONE, PESTICIDE COMPOSITIONS CONTAINING THEM AND PEST CONTROL METHODS. |
JPS64173A (en) * | 1987-06-22 | 1989-01-05 | Tanaka Kikinzoku Kogyo Kk | Organic noble metal ink |
IL105310A0 (en) * | 1992-04-16 | 1993-08-18 | Ciba Geigy Ag | Benzophenone derivatives |
-
1994
- 1994-12-20 DE DE59405428T patent/DE59405428D1/en not_active Expired - Fee Related
- 1994-12-20 AT AT94810737T patent/ATE163922T1/en not_active IP Right Cessation
- 1994-12-20 ES ES94810737T patent/ES2115190T3/en not_active Expired - Lifetime
- 1994-12-20 SG SG1996002103A patent/SG43002A1/en unknown
- 1994-12-20 EP EP94810737A patent/EP0662472B1/en not_active Expired - Lifetime
- 1994-12-21 NZ NZ270235A patent/NZ270235A/en unknown
-
1995
- 1995-01-03 CA CA002139465A patent/CA2139465A1/en not_active Abandoned
- 1995-01-04 CN CN95101143A patent/CN1108646A/en active Pending
- 1995-01-04 AU AU10041/95A patent/AU1004195A/en not_active Abandoned
- 1995-01-04 ZA ZA9528A patent/ZA9528B/en unknown
- 1995-01-04 KR KR1019950000142A patent/KR950032106A/en not_active Application Discontinuation
- 1995-01-05 JP JP7015510A patent/JPH07242618A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH07242618A (en) | 1995-09-19 |
CN1108646A (en) | 1995-09-20 |
EP0662472A1 (en) | 1995-07-12 |
EP0662472B1 (en) | 1998-03-11 |
AU1004195A (en) | 1995-07-13 |
KR950032106A (en) | 1995-12-20 |
ES2115190T3 (en) | 1998-06-16 |
DE59405428D1 (en) | 1998-04-16 |
ATE163922T1 (en) | 1998-03-15 |
ZA9528B (en) | 1995-07-13 |
SG43002A1 (en) | 1997-10-17 |
CA2139465A1 (en) | 1995-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU772823B2 (en) | Oxadiazine derivatives | |
US6022871A (en) | Oxadiazine derivatives | |
US5130331A (en) | Thienylthioureas, -isothioureas and -carbodiimides | |
US5405871A (en) | Benzophenonehydrazones | |
AU664846B2 (en) | Cyanophenylpyrroles | |
IE913499A1 (en) | Triazacyclohexane derivatives | |
US5763481A (en) | Vinylcarboxylic acid derivatives | |
HRP931151A2 (en) | Indazole derivatives | |
CA2081811A1 (en) | Butyric acid derivatives | |
NZ270235A (en) | Substituted sulphonyloxy benzophenone hydrazone derivatives; pesticides | |
US6664248B2 (en) | 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides | |
CA2094010A1 (en) | Benzophenone derivatives | |
IE921080A1 (en) | Amidine derivatives | |
AU640999B2 (en) | Nitroenamine derivatives | |
WO1995029889A1 (en) | Perhaloalkoxybenzenophenone hydrazones and their use as pesticides | |
MXPA93004052A (en) | Benzofenonhidrazo |